{"generated":"2026-09-10T19:17:09.890Z","commits":200,"records":4827,"changes":[{"id":"roche-genentech","kind":"company","name":"Roche / Genentech","route":"/companies/roche-genentech/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.roche.com\" }]"}]},{"id":"pfizer","kind":"company","name":"Pfizer (incl. Seagen)","route":"/companies/pfizer/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.pfizer.com\" }]"}]},{"id":"takeda","kind":"company","name":"Takeda","route":"/companies/takeda/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.takeda.com\" }]"}]},{"id":"sanofi","kind":"company","name":"Sanofi","route":"/companies/sanofi/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.sanofi.com\" }]"}]},{"id":"regeneron","kind":"company","name":"Regeneron","route":"/companies/regeneron/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.regeneron.com\" }]"}]},{"id":"servier","kind":"company","name":"Servier","route":"/companies/servier/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://servier.com\" }]"}]},{"id":"kelun-biotech","kind":"company","name":"Sichuan Kelun-Biotech","route":"/companies/kelun-biotech/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.kelun-biotech.com\" }]"}]},{"id":"systimmune","kind":"company","name":"SystImmune / Sichuan Biokin","route":"/companies/systimmune/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.systimmune.com\" }]"}]},{"id":"summit-therapeutics","kind":"company","name":"Summit Therapeutics","route":"/companies/summit-therapeutics/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.smmttx.com\" }]"}]},{"id":"zymeworks","kind":"company","name":"Zymeworks","route":"/companies/zymeworks/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.zymeworks.com\" }]"}]},{"id":"remegen","kind":"company","name":"RemeGen","route":"/companies/remegen/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.remegen.com\" }]"}]},{"id":"revolution-medicines","kind":"company","name":"Revolution Medicines","route":"/companies/revolution-medicines/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.revmed.com\" }]"}]},{"id":"syndax","kind":"company","name":"Syndax Pharmaceuticals","route":"/companies/syndax/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.syndax.com\" }]"}]},{"id":"replimune","kind":"company","name":"Replimune","route":"/companies/replimune/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.replimune.com\" }]"}]},{"id":"telix","kind":"company","name":"Telix Pharmaceuticals","route":"/companies/telix/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://telixpharma.com\" }]"}]},{"id":"rayzebio","kind":"company","name":"RayzeBio (BMS)","route":"/companies/rayzebio/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.rayzebio.com\" }]"}]},{"id":"terrapower-isotopes","kind":"company","name":"TerraPower Isotopes","route":"/companies/terrapower-isotopes/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.terrapower.com/isotopes\" }]"}]},{"id":"tempus","kind":"company","name":"Tempus AI","route":"/companies/tempus/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.tempus.com\" }]"}]},{"id":"paige","kind":"company","name":"Paige AI","route":"/companies/paige/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://paige.ai\" }]"}]},{"id":"pathai","kind":"company","name":"PathAI","route":"/companies/pathai/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.pathai.com\" }]"}]},{"id":"varian","kind":"company","name":"Varian (Siemens Healthineers)","route":"/companies/varian/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.varian.com\" }]"}]},{"id":"reflexion","kind":"company","name":"RefleXion Medical","route":"/companies/reflexion/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://reflexion.com\" }]"}]},{"id":"siemens-healthineers","kind":"company","name":"Siemens Healthineers","route":"/companies/siemens-healthineers/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.siemens-healthineers.com\" }]"}]},{"id":"united-imaging","kind":"company","name":"United Imaging","route":"/companies/united-imaging/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.united-imaging.com\" }]"}]},{"id":"serova","kind":"company","name":"Serova","route":"/companies/serova/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://pitchbook.com/profiles/company/1161350-47\" }]"}]},{"id":"vevo-therapeutics","kind":"company","name":"Vevo Therapeutics","route":"/companies/vevo-therapeutics/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.vevo.ai\" }]"}]},{"id":"xaira-therapeutics","kind":"company","name":"Xaira Therapeutics","route":"/companies/xaira-therapeutics/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://xaira.com\" }]"}]},{"id":"profluent-bio","kind":"company","name":"Profluent","route":"/companies/profluent-bio/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.profluent.bio\" }]"}]},{"id":"rigel-pharmaceuticals","kind":"company","name":"Rigel Pharmaceuticals","route":"/companies/rigel-pharmaceuticals/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.rigel.com\" }]"}]},{"id":"taiho","kind":"company","name":"Taiho Pharmaceutical (Otsuka)","route":"/companies/taiho/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/cholangiocarcinoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.taiho.co.jp/en/\" }]"}]},{"id":"transthera","kind":"company","name":"TransThera Sciences","route":"/companies/transthera/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/cholangiocarcinoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.transtherabio.com\" }]"}]},{"id":"y-mabs","kind":"company","name":"Y-mAbs Therapeutics","route":"/companies/y-mabs/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/neuroblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ymabs.com\" }]"}]},{"id":"springworks","kind":"company","name":"SpringWorks Therapeutics (Merck KGaA)","route":"/companies/springworks/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.springworkstx.com\" }]"}]},{"id":"us-worldmeds","kind":"company","name":"US WorldMeds","route":"/companies/us-worldmeds/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.usworldmeds.com\" }]"}]},{"id":"pharmamar","kind":"company","name":"PharmaMar","route":"/companies/pharmamar/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/sclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://pharmamar.com\" }]"}]},{"id":"henlius","kind":"company","name":"Shanghai Henlius Biotech","route":"/companies/henlius/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/spikes/sclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.henlius.com\" }]"}]},{"id":"oxford-biomedica","kind":"company","name":"OXB (Oxford Biomedica)","route":"/companies/oxford-biomedica/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.oxb.com\" }]"}]},{"id":"thermo-fisher","kind":"company","name":"Thermo Fisher Scientific","route":"/companies/thermo-fisher/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.thermofisher.com\" }]"}]},{"id":"touchlight","kind":"company","name":"Touchlight","route":"/companies/touchlight/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.touchlight.com\" }]"}]},{"id":"wuxi-xdc","kind":"company","name":"WuXi XDC","route":"/companies/wuxi-xdc/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.wuxixdc.com\" }]"}]},{"id":"samsung-biologics","kind":"company","name":"Samsung Biologics","route":"/companies/samsung-biologics/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://samsungbiologics.com\" }]"}]},{"id":"piramal-pharma-solutions","kind":"company","name":"Piramal Pharma Solutions","route":"/companies/piramal-pharma-solutions/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.piramalpharmasolutions.com\" }]"}]},{"id":"petnet-solutions","kind":"company","name":"PETNET Solutions (Siemens Healthineers)","route":"/companies/petnet-solutions/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.siemens-healthineers.com/molecular-imaging/petnet\" }]"}]},{"id":"shine-technologies","kind":"company","name":"SHINE Technologies","route":"/companies/shine-technologies/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.shinefusion.com\" }]"}]},{"id":"pacbio","kind":"company","name":"PacBio","route":"/companies/pacbio/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.pacb.com\" }]"}]},{"id":"oxford-nanopore","kind":"company","name":"Oxford Nanopore Technologies","route":"/companies/oxford-nanopore/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://nanoporetech.com\" }]"}]},{"id":"ultima-genomics","kind":"company","name":"Ultima Genomics","route":"/companies/ultima-genomics/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ultimagenomics.com\" }]"}]},{"id":"vizgen","kind":"company","name":"Vizgen","route":"/companies/vizgen/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://vizgen.com\" }]"}]},{"id":"philips","kind":"company","name":"Philips","route":"/companies/philips/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.philips.com\" }]"}]},{"id":"sectra","kind":"company","name":"Sectra","route":"/companies/sectra/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://sectra.com\" }]"}]},{"id":"proscia","kind":"company","name":"Proscia","route":"/companies/proscia/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://proscia.com\" }]"}]},{"id":"raysearch","kind":"company","name":"RaySearch Laboratories","route":"/companies/raysearch/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.raysearchlabs.com\" }]"}]},{"id":"sun-nuclear","kind":"company","name":"Sun Nuclear (Mirion)","route":"/companies/sun-nuclear/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.sunnuclear.com\" }]"}]},{"id":"therapanacea","kind":"company","name":"TheraPanacea","route":"/companies/therapanacea/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.therapanacea.eu\" }]"}]},{"id":"trinetx","kind":"company","name":"TriNetX","route":"/companies/trinetx/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://trinetx.com\" }]"}]},{"id":"veeva-systems","kind":"company","name":"Veeva Systems","route":"/companies/veeva-systems/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.veeva.com\" }]"}]},{"id":"science-37","kind":"company","name":"Science 37 (eMed)","route":"/companies/science-37/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.science37.com\" }]"}]},{"id":"sarah-cannon-research-institute","kind":"company","name":"Sarah Cannon Research Institute","route":"/companies/sarah-cannon-research-institute/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://sarahcannon.com\" }]"}]},{"id":"parexel","kind":"company","name":"Parexel","route":"/companies/parexel/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.parexel.com\" }]"}]},{"id":"quest-diagnostics","kind":"company","name":"Quest Diagnostics","route":"/companies/quest-diagnostics/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.questdiagnostics.com\" }]"}]},{"id":"terumo-bct","kind":"company","name":"Terumo Blood and Cell Technologies","route":"/companies/terumo-bct/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.terumobct.com\" }]"}]},{"id":"trasis","kind":"company","name":"Trasis","route":"/companies/trasis/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.trasis.com\" }]"}]},{"id":"sophia-genetics","kind":"company","name":"SOPHiA GENETICS","route":"/companies/sophia-genetics/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.sophiagenetics.com\" }]"}]},{"id":"qiagen","kind":"company","name":"QIAGEN","route":"/companies/qiagen/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.qiagen.com\" }]"}]},{"id":"velsera","kind":"company","name":"Velsera (Seven Bridges and Pierian)","route":"/companies/velsera/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://velsera.com\" }]"}]},{"id":"standard-biotools","kind":"company","name":"Standard BioTools (SomaLogic)","route":"/companies/standard-biotools/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.standardbio.com\" }]"}]},{"id":"streck","kind":"company","name":"Streck","route":"/companies/streck/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.streck.com\" }]"}]},{"id":"sakura-finetek","kind":"company","name":"Sakura Finetek","route":"/companies/sakura-finetek/","commit":"067761977c","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on every remaining company","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.sakura.eu\" }]"}]},{"id":"merck","kind":"company","name":"Merck & Co. (MSD)","route":"/companies/merck/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.merck.com\" }]"}]},{"id":"novartis","kind":"company","name":"Novartis","route":"/companies/novartis/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.novartis.com\" }]"}]},{"id":"medilink","kind":"company","name":"MediLink Therapeutics","route":"/companies/medilink/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.medilinkthera.com\" }]"}]},{"id":"merus","kind":"company","name":"Merus","route":"/companies/merus/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://merus.nl\" }]"}]},{"id":"nuvalent","kind":"company","name":"Nuvalent","route":"/companies/nuvalent/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.nuvalent.com\" }]"}]},{"id":"menarini","kind":"company","name":"Menarini / Stemline","route":"/companies/menarini/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.menarini.com\" }]"}]},{"id":"moderna","kind":"company","name":"Moderna","route":"/companies/moderna/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.modernatx.com\" }]"}]},{"id":"orano-med","kind":"company","name":"Orano Med","route":"/companies/orano-med/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.oranomed.com\" }]"}]},{"id":"natera","kind":"company","name":"Natera","route":"/companies/natera/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.natera.com\" }]"}]},{"id":"owkin","kind":"company","name":"Owkin","route":"/companies/owkin/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.owkin.com\" }]"}]},{"id":"novocure","kind":"company","name":"Novocure","route":"/companies/novocure/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.novocure.com\" }]"}]},{"id":"mevion","kind":"company","name":"Mevion Medical Systems","route":"/companies/mevion/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.mevion.com\" }]"}]},{"id":"morphosys","kind":"company","name":"MorphoSys (Novartis)","route":"/companies/morphosys/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.morphosys.com\" }]"}]},{"id":"microsoft-research","kind":"company","name":"Microsoft (Research and Health AI)","route":"/companies/microsoft-research/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.microsoft.com/en-us/research/\" }]"}]},{"id":"nvidia","kind":"company","name":"NVIDIA","route":"/companies/nvidia/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.nvidia.com/en-us/clara/biopharma/\" }]"}]},{"id":"northwest-biotherapeutics","kind":"company","name":"Northwest Biotherapeutics","route":"/companies/northwest-biotherapeutics/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/spikes/glioblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://nwbio.com\" }]"}]},{"id":"miltenyi-biotec","kind":"company","name":"Miltenyi Biotec","route":"/companies/miltenyi-biotec/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.miltenyibiotec.com\" }]"}]},{"id":"northstar-medical-radioisotopes","kind":"company","name":"NorthStar Medical Radioisotopes","route":"/companies/northstar-medical-radioisotopes/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.northstarnm.com\" }]"}]},{"id":"mgi-tech","kind":"company","name":"MGI Tech","route":"/companies/mgi-tech/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://en.mgi-tech.com\" }]"}]},{"id":"mim-software","kind":"company","name":"MIM Software (GE HealthCare)","route":"/companies/mim-software/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.mimsoftware.com\" }]"}]},{"id":"mvision-ai","kind":"company","name":"MVision AI","route":"/companies/mvision-ai/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://mvision.ai\" }]"}]},{"id":"medidata","kind":"company","name":"Medidata (Dassault Systèmes)","route":"/companies/medidata/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.medidata.com\" }]"}]},{"id":"oracle-health-sciences","kind":"company","name":"Oracle Health (Cerner) & Oracle Life Sciences","route":"/companies/oracle-health-sciences/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.oracle.com/health/\" }]"}]},{"id":"oneoncology","kind":"company","name":"OneOncology","route":"/companies/oneoncology/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.oneoncology.com\" }]"}]},{"id":"medpace","kind":"company","name":"Medpace","route":"/companies/medpace/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.medpace.com\" }]"}]},{"id":"neogenomics","kind":"company","name":"NeoGenomics","route":"/companies/neogenomics/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://neogenomics.com\" }]"}]},{"id":"omnicell","kind":"company","name":"Omnicell","route":"/companies/omnicell/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.omnicell.com\" }]"}]},{"id":"microsoft","kind":"company","name":"Microsoft (Health & Life Sciences)","route":"/companies/microsoft/","commit":"d37b709583","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.microsoft.com/en-us/industry/health\" }]"}]},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"history","before":"[\n      { year: 2000, title: \"Molecular portraits define the basal-like subtype\", note: \"Perou and Sørlie's expression profiling separates basal-like from luminal breast cancers.\", refs: [\"rna-seq\"] },\n      { year: 2...","after":"[\n      { year: 2000, title: \"Molecular portraits define the basal-like subtype\", note: \"Perou and Sørlie's expression profiling separates basal-like from luminal breast cancers.\", refs: [\"rna-seq\"] },\n      { year: 2..."}]},{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"history","before":"[\n      { year: 1987, title: \"Slamon links HER2 amplification to poor prognosis\" },\n      { year: 1998, title: \"Trastuzumab approved\", refs: [\"trastuzumab\"] },\n      { year: 2013, title: \"First solid-tumour ADC: T-DM1...","after":"[\n      { year: 1987, title: \"Slamon shows HER2 amplification marks aggressive disease, and a drug target\" },\n      { year: 1998, title: \"Trastuzumab approved\", refs: [\"trastuzumab\"] },\n      { year: 2013, title: \"Fir..."}]},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"burden","before":"\"~85% of lung cancer; lung cancer kills ~1.8 million people a year, more than any other cancer.\"","after":"\"~85% of lung cancer. Low-dose CT screening catches cancers in people at high risk while they are still curable (NLST, NELSON), and a dozen targetable drivers each have a matched drug. Lung cancer still accounts for a..."},{"field":"tldr","before":"\"Non-small-cell lung cancer is the biggest cancer killer, and the proving ground for precision medicine: a dozen targetable mutations, immunotherapy for the rest, and ADCs and bispecifics arriving now.\"","after":"\"Non-small-cell lung cancer is the proving ground for precision medicine: a dozen targetable mutations each with a matched pill, immunotherapy for the rest, and ADCs and bispecifics arriving now. Because most cases ar..."},{"field":"stateOfArt","before":"[\"5-year PFS 60% with lorlatinib in ALK+ disease.\", \"Adjuvant osimertinib halves death risk.\", \"First regimen to beat osimertinib (MARIPOSA) and first to beat pembrolizumab (ivonescimab, China).\"]","after":"[\"5-year PFS 60% with lorlatinib in ALK+ disease.\", \"Adjuvant osimertinib after surgery for EGFR-mutant disease roughly halves the risk of the cancer returning or of dying from it (ADAURA).\", \"First regimen to beat os..."}]},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"burden","before":"\"Pancreatic cancer causes about 500,000 cases per year with 5-year survival of about 13%, and is projected to be the second-leading cancer killer in the US by 2030.\"","after":"\"Pancreatic cancer causes about 500,000 cases per year. Surgery followed by mFOLFIRINOX cures a meaningful share of the ~20% found early, high-risk surveillance now finds most cancers in carriers at stage I, and the f..."},{"field":"tldr","before":"\"Pancreatic cancer is the deadliest common cancer. Almost every tumour carries a KRAS mutation, and for the first time drugs against it are in pivotal trials.\"","after":"\"Almost every pancreatic tumour carries a KRAS mutation, and for the first time drugs against it work: daraxonrasib nearly doubled survival in previously treated disease in 2026. Pancreatic cancer has been the hardest..."}]},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"openProblems","before":"[\"No effective screening.\", \"PARP resistance via BRCA reversion.\", \"Platinum-resistant disease remains lethal.\"]","after":"[\"No effective screening.\", \"PARP resistance via BRCA reversion.\", \"Platinum-resistant disease is the hardest setting; three drugs with survival benefit arrived in 2023-26 and each adds months, so combining and sequen..."}]},{"id":"glioblastoma","kind":"cancer","name":"Glioma & glioblastoma","route":"/cancers/glioblastoma/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"burden","before":"\"About 300,000 CNS tumours occur per year; glioblastoma median survival is about 15 months.\"","after":"\"About 300,000 CNS tumours occur per year, most of them not glioblastoma; IDH-mutant and paediatric low-grade gliomas can be lived with for decades and now have targeted drugs. Median survival for glioblastoma with ma..."},{"field":"tldr","before":"\"Glioblastoma is the most lethal brain tumour, barely improved since 2005. Low-grade IDH-mutant gliomas, by contrast, got their first targeted drug in 2024.\"","after":"\"Gliomas are now diagnosed by molecular class, and three classes got their first targeted drugs in 2024-25 (vorasidenib for IDH-mutant glioma, tovorafenib for BRAF-altered paediatric glioma, dordaviprone for H3 K27M)...."},{"field":"openProblems","before":"[\"Blood-brain barrier.\", \"Immunologically cold, heterogeneous, infiltrative.\", \"No progress in glioblastoma survival in 20 years.\"]","after":"[\"Blood-brain barrier.\", \"Immunologically cold, heterogeneous, infiltrative.\", \"Glioblastoma: no systemic drug has beaten the 2005 standard; getting drugs across the blood-brain barrier is the crux.\"]"}]},{"id":"thyroid","kind":"cancer","name":"Thyroid cancer","route":"/cancers/thyroid/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"openProblems","before":"[\"Overdiagnosis of microcarcinoma.\", \"Anaplastic thyroid cancer remains lethal.\"]","after":"[\"Overdiagnosis of microcarcinoma.\", \"Anaplastic thyroid cancer: BRAF V600E cases now respond to dabrafenib-trametinib, often enough to allow surgery; the 60% without the mutation still have few options.\"]"}]},{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"openProblems","before":"[\"TP53-mutant AML remains lethal.\", \"Older patients.\"]","after":"[\"TP53-mutant AML: no drug class has yet improved survival, so it is the priority for new mechanisms.\", \"Older patients.\"]"}]},{"id":"waldenstrom","kind":"cancer","name":"Waldenström macroglobulinaemia","route":"/cancers/waldenstrom/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"openProblems","before":"[\"Indefinite BTKi therapy: cost, toxicity and resistance (BTK C481S).\", \"CXCR4-mutant disease responds slower and shallower.\", \"No approved therapy specific to IgM-related neuropathy.\", \"Transformation to DLBCL (5-10%...","after":"[\"Indefinite BTKi therapy: cost, toxicity and resistance (BTK C481S).\", \"CXCR4-mutant disease responds slower and shallower.\", \"No approved therapy specific to IgM-related neuropathy.\", \"Transformation to DLBCL (5-10%..."}]},{"id":"merkel-cell-carcinoma","kind":"cancer","name":"Merkel cell carcinoma","route":"/cancers/merkel-cell-carcinoma/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"burden","before":"\"Merkel cell carcinoma causes about 3,000 cases per year in the US and rising; median age is ~75; it is roughly 40 times rarer than melanoma but twice as lethal stage for stage.\"","after":"\"Merkel cell carcinoma causes about 3,000 cases per year in the US and rising; median age is ~75; it is roughly 40 times rarer than melanoma and more likely to spread stage for stage, which is why immunotherapy's dura..."}]},{"id":"cutaneous-scc","kind":"cancer","name":"Cutaneous squamous cell carcinoma","route":"/cancers/cutaneous-scc/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"burden","before":"\"Second most common skin cancer; over one million cases per year in the US; about 2-5% metastasise, but that is still several thousand deaths a year.\"","after":"\"Second most common skin cancer; over one million cases per year in the US, almost all cured by removal; about 2-5% metastasise, which still amounts to several thousand deaths a year and is where PD-1 immunotherapy no..."}]},{"id":"basal-cell-carcinoma","kind":"cancer","name":"Basal cell carcinoma","route":"/cancers/basal-cell-carcinoma/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"tldr","before":"\"Basal cell carcinoma is the most common cancer of all, caused by sun exposure and almost never fatal. Nearly all are removed surgically; the rare advanced cases are treated with drugs that block the hedgehog signalli...","after":"\"Basal cell carcinoma is the most common cancer of all, caused by sun exposure and almost never life-threatening. Nearly all are removed surgically; the rare advanced cases are treated with drugs that block the hedgeh..."}]},{"id":"appendiceal","kind":"cancer","name":"Appendiceal cancer and pseudomyxoma peritonei","route":"/cancers/appendiceal/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"stateOfArt","before":"[\"CRS-HIPEC turned PMP from a fatal disease into one with long survival for low-grade histology.\", \"Grade, not stage, drives therapy: the 2024 randomised trial ended routine chemotherapy for low-grade mucinous carcino...","after":"[\"CRS-HIPEC turned PMP from a disease with no effective treatment into one with long survival for low-grade histology.\", \"Grade, not stage, drives therapy: the 2024 randomised trial ended routine chemotherapy for low-..."}]},{"id":"medulloblastoma","kind":"cancer","name":"Medulloblastoma","route":"/cancers/medulloblastoma/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"summary","before":"\"Medulloblastoma is an embryonal tumour of the posterior fossa with four consensus molecular subgroups (WNT, SHH, Group 3, Group 4) that differ in age, genetics, metastatic tendency and survival: WNT (~10%, CTNNB1 mut...","after":"\"Medulloblastoma is an embryonal tumour of the posterior fossa with four consensus molecular subgroups (WNT, SHH, Group 3, Group 4) that differ in age, genetics, metastatic tendency and survival: WNT (~10%, CTNNB1 mut..."},{"field":"openProblems","before":"[\"Group 3 MYC-amplified and SHH TP53-mutant tumours: survival under 50%.\", \"Relapse is almost always fatal after craniospinal irradiation.\", \"Neurocognitive, endocrine and hearing sequelae in survivors.\", \"Infants: cu...","after":"[\"Group 3 MYC-amplified and SHH TP53-mutant tumours: survival under 50%.\", \"Relapse after craniospinal irradiation is rarely curable; it is where new approaches are most needed.\", \"Neurocognitive, endocrine and hearin..."}]},{"id":"osteosarcoma","kind":"cancer","name":"Osteosarcoma","route":"/cancers/osteosarcoma/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"tldr","before":"\"Osteosarcoma is the most common bone cancer, mostly in teenagers. Chemotherapy plus surgery cures about two-thirds when it has not spread, but survival has not improved in 30 years and no new drug has worked in a lar...","after":"\"Osteosarcoma is the most common bone cancer, mostly in teenagers. Chemotherapy plus surgery cures about two-thirds when it has not spread; because no new drug has beaten that chemotherapy in a large trial in 30 years..."}]},{"id":"wilms-tumor","kind":"cancer","name":"Wilms tumour (nephroblastoma)","route":"/cancers/wilms-tumor/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"openProblems","before":"[\"Diffuse anaplastic and relapsed disease: survival ~50% or lower.\", \"Global inequity: Wilms is curable, yet most children with it worldwide die.\", \"Late effects of doxorubicin and radiation in 90% survivors.\", \"Bilat...","after":"[\"Diffuse anaplastic and relapsed disease: survival ~50% or lower.\", \"Global inequity: Wilms is curable, yet most children with it worldwide lack access to the treatment that cures it; adapted regimens (SIOP PODC) are..."}]},{"id":"retinoblastoma","kind":"cancer","name":"Retinoblastoma","route":"/cancers/retinoblastoma/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"tldr","before":"\"An eye cancer of infants caused by loss of the RB1 gene, the first tumour-suppressor gene ever found. In rich countries almost every child survives and most eyes are saved by chemotherapy delivered through the eye's ...","after":"\"An eye cancer of infants caused by loss of the RB1 gene, the first tumour-suppressor gene ever found. In rich countries almost every child survives and most eyes are saved by chemotherapy delivered through the eye's ..."},{"field":"summary","before":"\"Retinoblastoma arises from biallelic loss of RB1 in developing retinal cells (Knudson's two-hit hypothesis, 1971; RB1 cloned 1986), or rarely from MYCN amplification with intact RB1. Heritable disease (~40%, germline...","after":"\"Retinoblastoma arises from biallelic loss of RB1 in developing retinal cells (Knudson's two-hit hypothesis, 1971; RB1 cloned 1986), or rarely from MYCN amplification with intact RB1. Heritable disease (~40%, germline..."},{"field":"standardOfCare","before":"[\n      { setting: \"Advanced unilateral (group E, no vision potential)\", approach: \"Primary enucleation with long optic nerve segment; adjuvant chemotherapy (VEC) for high-risk pathology; orbital implant.\", refs: [\"vi...","after":"[\n      { setting: \"Advanced unilateral (group E, no vision potential)\", approach: \"Primary enucleation with long optic nerve segment; adjuvant chemotherapy (VEC) for high-risk pathology; orbital implant.\", refs: [\"vi..."},{"field":"stateOfArt","before":"[\"Intra-arterial chemotherapy saves eyes that would have been removed, with globe salvage ~70-90% in group D and few systemic effects.\", \"Radiation has been almost eliminated because of second cancers in RB1 carriers....","after":"[\"Intra-arterial chemotherapy saves eyes that would have been removed, with globe salvage ~70-90% in group D and few systemic effects.\", \"Radiation has been almost eliminated because of second cancers in RB1 carriers...."},{"field":"openProblems","before":"[\"Late diagnosis and death in low-income countries; paediatric ophthalmology access.\", \"Second primary cancers in RB1 carriers across life.\", \"Vision outcomes after eye salvage.\", \"Metastatic and CNS disease.\"]","after":"[\"Late diagnosis in low-income countries; paediatric ophthalmology access is the lever.\", \"Second primary cancers in RB1 carriers across life.\", \"Vision outcomes after eye salvage.\", \"Metastatic and CNS disease.\"]"}]},{"id":"cancer-of-unknown-primary","kind":"cancer","name":"Cancer of unknown primary (CUP)","route":"/cancers/cancer-of-unknown-primary/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"tldr","before":"\"Cancer found already spread, where doctors cannot find where it started. Most cases are treated with general-purpose chemotherapy and do poorly; molecular tests to guess the origin or find a drug target are slowly ch...","after":"\"Cancer found already spread, where doctors cannot find where it started. Genomic profiling finds a drug target in about a third of cases and tumour-agnostic approvals apply directly; the rest still rely on general-pu..."}]},{"id":"nasopharyngeal","kind":"cancer","name":"Nasopharyngeal carcinoma","route":"/cancers/nasopharyngeal/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"openProblems","before":"[\"Radiation late effects in a disease cured young.\", \"Western access to PD-1 inhibitors studied in Asia; regulatory lag.\", \"EBV-targeted therapy (vaccines, EBV-specific T cells) still investigational.\", \"Distant metas...","after":"[\"Radiation late effects in a disease cured young.\", \"Western access to PD-1 inhibitors studied in Asia; regulatory lag.\", \"EBV-targeted therapy (vaccines, EBV-specific T cells) still investigational.\", \"Distant metas..."}]},{"id":"kaposi-sarcoma","kind":"cancer","name":"Kaposi sarcoma","route":"/cancers/kaposi-sarcoma/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/gap-cancers.ts","type":"changed","fields":[{"field":"openProblems","before":"[\"Access to effective chemotherapy and ART-linked cancer care in sub-Saharan Africa.\", \"KS in people with suppressed HIV and normal CD4 counts (unexplained).\", \"No antiviral therapy targets latent KSHV.\", \"Endemic chi...","after":"[\"Access to effective chemotherapy and ART-linked cancer care in sub-Saharan Africa.\", \"KS in people with suppressed HIV and normal CD4 counts (unexplained).\", \"No antiviral therapy targets latent KSHV.\", \"Endemic chi..."}]},{"id":"glioma-car-t","kind":"technology","name":"CAR-T for glioma (IL13Rα2, GD2, EGFRvIII, multi-target)","route":"/technologies/glioma-car-t/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/glioblastoma.ts","type":"changed","fields":[{"field":"tldr","before":"\"Engineered immune cells delivered directly into the brain or spinal fluid. Some children with an incurable brainstem tumour have had striking, if temporary, responses.\"","after":"\"Engineered immune cells delivered directly into the brain or spinal fluid. Some children with diffuse midline glioma, a brainstem tumour with no curative treatment, have had striking, if temporary, responses.\""}]},{"id":"h3k27m","kind":"term","name":"H3 K27M (diffuse midline glioma)","route":"/terms/h3k27m/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/glioblastoma.ts","type":"changed","fields":[{"field":"tldr","before":"\"A single change in a histone protein that defines the most lethal childhood brain tumour, and now the target of the first approved drug for it.\"","after":"\"A single change in a histone protein that defines diffuse midline glioma, the childhood brain tumour with the fewest treatment options, and now the target of the first approved drug for it.\""}]},{"id":"hgsoc","kind":"term","name":"High-grade serous ovarian carcinoma (HGSOC)","route":"/terms/hgsoc/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/spikes/ovarian.ts","type":"changed","fields":[{"field":"tldr","before":"\"High-grade serous ovarian carcinoma is the most common and most lethal type of ovarian cancer; it actually starts in the fallopian tube and almost always has a broken TP53 gene.\"","after":"\"High-grade serous ovarian carcinoma is the most common type of ovarian cancer and the one most often found late; it actually starts in the fallopian tube and almost always has a broken TP53 gene, and it is the type P..."},{"field":"summary","before":"\"About 70% of ovarian cancer deaths. Near-universal TP53 mutation, ~50% homologous recombination deficiency (including ~20% BRCA1/2), extensive copy-number instability, few recurrent targetable mutations. Arises from ...","after":"\"The type behind about 70% of ovarian cancer deaths, and the one where maintenance therapy has changed the most. Near-universal TP53 mutation, ~50% homologous recombination deficiency (including ~20% BRCA1/2), extensi..."}]},{"id":"kit","kind":"target","name":"KIT","route":"/targets/kit/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/targets.ts","type":"changed","fields":[{"field":"tldr","before":"\"KIT mutation is the driver behind most gastrointestinal stromal tumours, and the reason imatinib turned a lethal sarcoma into a chronic disease.\"","after":"\"KIT mutation is the driver behind most gastrointestinal stromal tumours, and the reason imatinib turned a sarcoma with a median survival of about a year into a chronic disease.\""}]},{"id":"metastasis","kind":"term","name":"Metastasis","route":"/terms/metastasis/","commit":"28a6975696","date":"2026-09-10","author":"Jude Gomila","message":"Tone pass: solution and mechanism first; frightening figures behind a click","file":"src/data/terms-basics.ts","type":"changed","fields":[{"field":"tldr","before":"\"Cancer that has spread from where it started to distant parts of the body, travelling through the blood or lymph. Metastasis is what makes most cancers deadly.\"","after":"\"Cancer that has spread from where it started to distant parts of the body, travelling through the blood or lymph. Metastasis is why staging scans look at the whole body, and the setting in which most new cancer drugs..."}]},{"id":"johnson-johnson","kind":"company","name":"Johnson & Johnson","route":"/companies/johnson-johnson/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.jnj.com\" }]"}]},{"id":"jazz","kind":"company","name":"Jazz Pharmaceuticals","route":"/companies/jazz/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.jazzpharma.com\" }]"}]},{"id":"iovance","kind":"company","name":"Iovance Biotherapeutics","route":"/companies/iovance/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.iovance.com\" }]"}]},{"id":"legend-biotech","kind":"company","name":"Legend Biotech","route":"/companies/legend-biotech/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.legendbiotech.com\" }]"}]},{"id":"lantheus","kind":"company","name":"Lantheus","route":"/companies/lantheus/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.lantheus.com\" }]"}]},{"id":"itm","kind":"company","name":"ITM Isotope Technologies Munich","route":"/companies/itm/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://itm-radiopharma.com\" }]"}]},{"id":"intuitive-surgical","kind":"company","name":"Intuitive Surgical","route":"/companies/intuitive-surgical/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.intuitive.com\" }]"}]},{"id":"insightec","kind":"company","name":"Insightec","route":"/companies/insightec/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.insightec.com\" }]"}]},{"id":"kaiko-ai","kind":"company","name":"kaiko.ai","route":"/companies/kaiko-ai/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.kaiko.ai\" }]"}]},{"id":"lila-sciences","kind":"company","name":"Lila Sciences","route":"/companies/lila-sciences/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.lila.ai\" }]"}]},{"id":"latent-labs","kind":"company","name":"Latent Labs","route":"/companies/latent-labs/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.latentlabs.com\" }]"}]},{"id":"hengrui","kind":"company","name":"Jiangsu Hengrui Pharmaceuticals","route":"/companies/hengrui/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.hengrui.com\" }]"}]},{"id":"macrogenics","kind":"company","name":"MacroGenics","route":"/companies/macrogenics/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.macrogenics.com\" }]"}]},{"id":"incyte","kind":"company","name":"Incyte","route":"/companies/incyte/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/spikes/cholangiocarcinoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.incyte.com\" }]"}]},{"id":"karyopharm","kind":"company","name":"Karyopharm Therapeutics","route":"/companies/karyopharm/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/spikes/ovarian.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.karyopharm.com\" }]"}]},{"id":"ipsen","kind":"company","name":"Ipsen","route":"/companies/ipsen/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/spikes/pancreatic.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ipsen.com\" }]"}]},{"id":"lonza","kind":"company","name":"Lonza","route":"/companies/lonza/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.lonza.com\" }]"}]},{"id":"jubilant-radiopharma","kind":"company","name":"Jubilant Radiopharma","route":"/companies/jubilant-radiopharma/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.jubilantradiopharma.com\" }]"}]},{"id":"leica-biosystems","kind":"company","name":"Leica Biosystems (Danaher)","route":"/companies/leica-biosystems/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.leicabiosystems.com\" }]"}]},{"id":"indica-labs","kind":"company","name":"Indica Labs","route":"/companies/indica-labs/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://indicalab.com\" }]"}]},{"id":"limbus-ai","kind":"company","name":"Limbus AI","route":"/companies/limbus-ai/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://limbus.ai\" }]"}]},{"id":"komodo-health","kind":"company","name":"Komodo Health","route":"/companies/komodo-health/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.komodohealth.com\" }]"}]},{"id":"medable","kind":"company","name":"Medable","route":"/companies/medable/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.medable.com\" }]"}]},{"id":"mckesson-us-oncology","kind":"company","name":"McKesson / The US Oncology Network","route":"/companies/mckesson-us-oncology/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.usoncology.com\" }]"}]},{"id":"iqvia","kind":"company","name":"IQVIA","route":"/companies/iqvia/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.iqvia.com\" }]"}]},{"id":"indivumed","kind":"company","name":"Indivumed","route":"/companies/indivumed/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.indivumed.com\" }]"}]},{"id":"labcorp","kind":"company","name":"Labcorp","route":"/companies/labcorp/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.labcorp.com\" }]"}]},{"id":"kaiku-health","kind":"company","name":"Kaiku Health (Elekta)","route":"/companies/kaiku-health/","commit":"f7782c9f5f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on a further thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.elekta.com/products/oncology-informatics/\" }]"}]},{"id":"gilead","kind":"company","name":"Gilead Sciences (incl. Kite)","route":"/companies/gilead/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.gilead.com\" }]"}]},{"id":"gsk","kind":"company","name":"GSK","route":"/companies/gsk/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.gsk.com\" }]"}]},{"id":"genmab","kind":"company","name":"Genmab","route":"/companies/genmab/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.genmab.com\" }]"}]},{"id":"immunocore","kind":"company","name":"Immunocore","route":"/companies/immunocore/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.immunocore.com\" }]"}]},{"id":"fusion-pharma","kind":"company","name":"Fusion Pharmaceuticals (AstraZeneca)","route":"/companies/fusion-pharma/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.astrazeneca.com\" }]"}]},{"id":"foundation-medicine","kind":"company","name":"Foundation Medicine (Roche)","route":"/companies/foundation-medicine/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.foundationmedicine.com\" }]"}]},{"id":"guardant-health","kind":"company","name":"Guardant Health","route":"/companies/guardant-health/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://guardanthealth.com\" }]"}]},{"id":"grail","kind":"company","name":"GRAIL","route":"/companies/grail/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://grail.com\" }]"}]},{"id":"illumina","kind":"company","name":"Illumina","route":"/companies/illumina/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.illumina.com\" }]"}]},{"id":"histosonics","kind":"company","name":"HistoSonics","route":"/companies/histosonics/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://histosonics.com\" }]"}]},{"id":"iba","kind":"company","name":"IBA (Ion Beam Applications)","route":"/companies/iba/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.iba-worldwide.com\" }]"}]},{"id":"ge-healthcare","kind":"company","name":"GE HealthCare","route":"/companies/ge-healthcare/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.gehealthcare.com\" }]"}]},{"id":"google-deepmind","kind":"company","name":"Google DeepMind (and Google Research)","route":"/companies/google-deepmind/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://deepmind.google\" }]"}]},{"id":"histai","kind":"company","name":"HistAI","route":"/companies/histai/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://hist.ai\" }]"}]},{"id":"genesis-molecular-ai","kind":"company","name":"Genesis Molecular AI (formerly Genesis Therapeutics)","route":"/companies/genesis-molecular-ai/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.genesistherapeutics.ai\" }]"}]},{"id":"iambic-therapeutics","kind":"company","name":"Iambic Therapeutics","route":"/companies/iambic-therapeutics/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.iambic.ai\" }]"}]},{"id":"exelixis","kind":"company","name":"Exelixis","route":"/companies/exelixis/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/spikes/rcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.exelixis.com\" }]"}]},{"id":"immunitybio","kind":"company","name":"ImmunityBio","route":"/companies/immunitybio/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://immunitybio.com\" }]"}]},{"id":"ferring","kind":"company","name":"Ferring Pharmaceuticals","route":"/companies/ferring/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ferring.com\" }]"}]},{"id":"galapagos","kind":"company","name":"Galapagos","route":"/companies/galapagos/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.glpg.com\" }]"}]},{"id":"hamamatsu","kind":"company","name":"Hamamatsu Photonics","route":"/companies/hamamatsu/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.hamamatsu.com\" }]"}]},{"id":"flatiron-health","kind":"company","name":"Flatiron Health (Roche)","route":"/companies/flatiron-health/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://flatiron.com\" }]"}]},{"id":"florida-cancer-specialists","kind":"company","name":"Florida Cancer Specialists & Research Institute","route":"/companies/florida-cancer-specialists/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://flcancer.com\" }]"}]},{"id":"icon-plc","kind":"company","name":"ICON plc","route":"/companies/icon-plc/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.iconplc.com\" }]"}]},{"id":"fortrea","kind":"company","name":"Fortrea","route":"/companies/fortrea/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.fortrea.com\" }]"}]},{"id":"hub-organoids","kind":"company","name":"HUB Organoids","route":"/companies/hub-organoids/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.huborganoids.nl\" }]"}]},{"id":"google-health","kind":"company","name":"Google (Health, DeepMind, Verily)","route":"/companies/google-health/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://health.google\" }]"}]},{"id":"fresenius-kabi","kind":"company","name":"Fresenius Kabi","route":"/companies/fresenius-kabi/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.fresenius-kabi.com\" }]"}]},{"id":"fujifilm-diosynth","kind":"company","name":"FUJIFILM Diosynth Biotechnologies","route":"/companies/fujifilm-diosynth/","commit":"d1f1037d6e","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://fujifilmdiosynth.com\" }]"}]},{"id":"daiichi-sankyo","kind":"company","name":"Daiichi Sankyo","route":"/companies/daiichi-sankyo/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.daiichisankyo.com\" }]"}]},{"id":"eli-lilly","kind":"company","name":"Eli Lilly (incl. Loxo)","route":"/companies/eli-lilly/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.lilly.com\" }]"}]},{"id":"dualitybio","kind":"company","name":"Duality Biotherapeutics","route":"/companies/dualitybio/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.dualitybiotherapeutics.com\" }]"}]},{"id":"corcept","kind":"company","name":"Corcept Therapeutics","route":"/companies/corcept/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.corcept.com\" }]"}]},{"id":"exact-sciences","kind":"company","name":"Exact Sciences (Abbott)","route":"/companies/exact-sciences/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.exactsciences.com\" }]"}]},{"id":"elekta","kind":"company","name":"Elekta","route":"/companies/elekta/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.elekta.com\" }]"}]},{"id":"evolutionaryscale","kind":"company","name":"EvolutionaryScale","route":"/companies/evolutionaryscale/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.evolutionaryscale.ai\" }]"}]},{"id":"chai-discovery","kind":"company","name":"Chai Discovery","route":"/companies/chai-discovery/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.chaidiscovery.com\" }]"}]},{"id":"cradle-bio","kind":"company","name":"Cradle","route":"/companies/cradle-bio/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cradle.bio\" }]"}]},{"id":"chan-zuckerberg-initiative","kind":"company","name":"Chan Zuckerberg Initiative (Biohub)","route":"/companies/chan-zuckerberg-initiative/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://chanzuckerberg.com/science/\" }]"}]},{"id":"samsung-medical-center","kind":"institution","name":"Samsung Medical Center","route":"/institutions/samsung-medical-center/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.samsunghospital.com\" }]"}]},{"id":"royal-marsden","kind":"institution","name":"The Royal Marsden","route":"/institutions/royal-marsden/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.royalmarsden.nhs.uk\" }]"}]},{"id":"snuh","kind":"institution","name":"Seoul National University Hospital","route":"/institutions/snuh/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.snuh.org\" }]"}]},{"id":"severance","kind":"institution","name":"Severance Hospital, Yonsei University","route":"/institutions/severance/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://sev.severance.healthcare\" }]"}]},{"id":"the-christie","kind":"institution","name":"The Christie NHS Foundation Trust","route":"/institutions/the-christie/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.christie.nhs.uk\" }]"}]},{"id":"uke-hamburg","kind":"institution","name":"Universitätsklinikum Hamburg-Eppendorf","route":"/institutions/uke-hamburg/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.uke.de\" }]"}]},{"id":"vall-dhebron","kind":"institution","name":"Vall d'Hebron University Hospital / VHIO","route":"/institutions/vall-dhebron/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://vhio.net\" }]"}]},{"id":"stanford","kind":"institution","name":"Stanford Health Care / Stanford Cancer Institute","route":"/institutions/stanford/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://cancer.stanford.edu\" }]"}]},{"id":"uniklinik-koeln","kind":"institution","name":"Uniklinik Köln (CIO)","route":"/institutions/uniklinik-koeln/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.uk-koeln.de\" }]"}]},{"id":"ucsf","kind":"institution","name":"UCSF Helen Diller Family Comprehensive Cancer Center","route":"/institutions/ucsf/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://cancer.ucsf.edu\" }]"}]},{"id":"mount-sinai","kind":"institution","name":"The Mount Sinai Hospital / Tisch Cancer Institute","route":"/institutions/mount-sinai/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.mountsinai.org/care/cancer\" }]"}]},{"id":"michigan-rogel","kind":"institution","name":"University of Michigan Rogel Cancer Center","route":"/institutions/michigan-rogel/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.rogelcancercenter.org\" }]"}]},{"id":"wustl-siteman","kind":"institution","name":"Siteman Cancer Center, Washington University","route":"/institutions/wustl-siteman/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://siteman.wustl.edu\" }]"}]},{"id":"ucla-jonsson","kind":"institution","name":"UCLA Jonsson Comprehensive Cancer Center","route":"/institutions/ucla-jonsson/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.uclahealth.org/cancer\" }]"}]},{"id":"roswell-park","kind":"institution","name":"Roswell Park Comprehensive Cancer Center","route":"/institutions/roswell-park/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.roswellpark.org\" }]"}]},{"id":"francis-crick","kind":"institution","name":"The Francis Crick Institute","route":"/institutions/francis-crick/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.crick.ac.uk\" }]"}]},{"id":"icr-london","kind":"institution","name":"The Institute of Cancer Research","route":"/institutions/icr-london/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.icr.ac.uk\" }]"}]},{"id":"sysucc","kind":"institution","name":"Sun Yat-sen University Cancer Center","route":"/institutions/sysucc/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.sysucc.org.cn\" }]"}]},{"id":"tata-memorial","kind":"institution","name":"Tata Memorial Centre","route":"/institutions/tata-memorial/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://tmc.gov.in\" }]"}]},{"id":"day-one-biopharmaceuticals","kind":"company","name":"Day One Biopharmaceuticals","route":"/companies/day-one-biopharmaceuticals/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/spikes/glioblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.dayonebio.com\" }]"}]},{"id":"elicio-therapeutics","kind":"company","name":"Elicio Therapeutics","route":"/companies/elicio-therapeutics/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/spikes/pancreatic.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://elicio.com\" }]"}]},{"id":"essa-pharma","kind":"company","name":"ESSA Pharma","route":"/companies/essa-pharma/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://essapharma.com\" }]"}]},{"id":"eisai","kind":"company","name":"Eisai","route":"/companies/eisai/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/spikes/rcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.eisai.com\" }]"}]},{"id":"deciphera","kind":"company","name":"Deciphera Pharmaceuticals (Ono)","route":"/companies/deciphera/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.deciphera.com\" }]"}]},{"id":"cytiva","kind":"company","name":"Cytiva (Danaher)","route":"/companies/cytiva/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cytivalifesciences.com\" }]"}]},{"id":"charles-river","kind":"company","name":"Charles River Laboratories","route":"/companies/charles-river/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.criver.com\" }]"}]},{"id":"eckert-ziegler","kind":"company","name":"Eckert & Ziegler","route":"/companies/eckert-ziegler/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ezag.com\" }]"}]},{"id":"element-biosciences","kind":"company","name":"Element Biosciences","route":"/companies/element-biosciences/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.elementbiosciences.com\" }]"}]},{"id":"concertai","kind":"company","name":"ConcertAI","route":"/companies/concertai/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.concertai.com\" }]"}]},{"id":"cota-healthcare","kind":"company","name":"COTA","route":"/companies/cota-healthcare/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://cotahealthcare.com\" }]"}]},{"id":"datavant","kind":"company","name":"Datavant","route":"/companies/datavant/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.datavant.com\" }]"}]},{"id":"epic-systems","kind":"company","name":"Epic Systems","route":"/companies/epic-systems/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.epic.com\" }]"}]},{"id":"clario","kind":"company","name":"Clario","route":"/companies/clario/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://clario.com\" }]"}]},{"id":"discovery-life-sciences","kind":"company","name":"Discovery Life Sciences","route":"/companies/discovery-life-sciences/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.dls.com\" }]"}]},{"id":"civica-rx","kind":"company","name":"Civica Rx","route":"/companies/civica-rx/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://civicarx.org\" }]"}]},{"id":"cryoport","kind":"company","name":"Cryoport","route":"/companies/cryoport/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cryoport.com\" }]"}]},{"id":"comecer","kind":"company","name":"Comecer (ATS)","route":"/companies/comecer/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.comecer.com\" }]"}]},{"id":"dnanexus","kind":"company","name":"DNAnexus","route":"/companies/dnanexus/","commit":"1fcb3c8eab","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on the remaining institutions and thirty more companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.dnanexus.com\" }]"}]},{"id":"astrazeneca","kind":"company","name":"AstraZeneca","route":"/companies/astrazeneca/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.astrazeneca.com\" }]"}]},{"id":"bms","kind":"company","name":"Bristol Myers Squibb","route":"/companies/bms/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bms.com\" }]"}]},{"id":"abbvie","kind":"company","name":"AbbVie (incl. ImmunoGen, Capstan)","route":"/companies/abbvie/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.abbvie.com\" }]"}]},{"id":"amgen","kind":"company","name":"Amgen","route":"/companies/amgen/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.amgen.com\" }]"}]},{"id":"bayer","kind":"company","name":"Bayer","route":"/companies/bayer/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bayer.com\" }]"}]},{"id":"astellas","kind":"company","name":"Astellas","route":"/companies/astellas/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.astellas.com\" }]"}]},{"id":"boehringer-ingelheim","kind":"company","name":"Boehringer Ingelheim","route":"/companies/boehringer-ingelheim/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.boehringer-ingelheim.com\" }]"}]},{"id":"akeso","kind":"company","name":"Akeso","route":"/companies/akeso/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.akesobio.com\" }]"}]},{"id":"adc-therapeutics","kind":"company","name":"ADC Therapeutics","route":"/companies/adc-therapeutics/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://adctherapeutics.com\" }]"}]},{"id":"beone","kind":"company","name":"BeOne Medicines (formerly BeiGene)","route":"/companies/beone/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.beonemedicines.com\" }]"}]},{"id":"arvinas","kind":"company","name":"Arvinas","route":"/companies/arvinas/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.arvinas.com\" }]"}]},{"id":"celcuity","kind":"company","name":"Celcuity","route":"/companies/celcuity/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.celcuity.com\" }]"}]},{"id":"biontech","kind":"company","name":"BioNTech","route":"/companies/biontech/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.biontech.com\" }]"}]},{"id":"carsgen","kind":"company","name":"CARsgen Therapeutics","route":"/companies/carsgen/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.carsgen.com\" }]"}]},{"id":"adaptimmune","kind":"company","name":"Adaptimmune","route":"/companies/adaptimmune/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.adaptimmune.com\" }]"}]},{"id":"caris","kind":"company","name":"Caris Life Sciences","route":"/companies/caris/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.carislifesciences.com\" }]"}]},{"id":"bostongene","kind":"company","name":"BostonGene","route":"/companies/bostongene/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://bostongene.com\" }]"}]},{"id":"cancer-commons","kind":"company","name":"Cancer Commons","route":"/companies/cancer-commons/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://cancercommons.org\" }]"}]},{"id":"institute-for-protein-design","kind":"institution","name":"Institute for Protein Design (University of Washington)","route":"/institutions/institute-for-protein-design/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ipd.uw.edu\" }]"}]},{"id":"providence-health","kind":"institution","name":"Providence Health & Services","route":"/institutions/providence-health/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.providence.org\" }]"}]},{"id":"mskcc","kind":"institution","name":"Memorial Sloan Kettering Cancer Center","route":"/institutions/mskcc/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.mskcc.org\" }]"}]},{"id":"md-anderson","kind":"institution","name":"MD Anderson Cancer Center","route":"/institutions/md-anderson/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.mdanderson.org\" }]"}]},{"id":"mayo-clinic","kind":"institution","name":"Mayo Clinic","route":"/institutions/mayo-clinic/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.mayoclinic.org\" }]"}]},{"id":"princess-margaret","kind":"institution","name":"Princess Margaret Cancer Centre","route":"/institutions/princess-margaret/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.uhn.ca/PrincessMargaret\" }]"}]},{"id":"johns-hopkins","kind":"institution","name":"Johns Hopkins Hospital / Sidney Kimmel Comprehensive Cancer Center","route":"/institutions/johns-hopkins/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.hopkinsmedicine.org/kimmel-cancer-center\" }]"}]},{"id":"ieo-milan","kind":"institution","name":"IEO – European Institute of Oncology","route":"/institutions/ieo-milan/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ieo.it\" }]"}]},{"id":"ncc-japan","kind":"institution","name":"National Cancer Center Hospital","route":"/institutions/ncc-japan/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.ncc.go.jp/en/\" }]"}]},{"id":"peter-mac","kind":"institution","name":"Peter MacCallum Cancer Centre","route":"/institutions/peter-mac/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.petermac.org\" }]"}]},{"id":"mgh","kind":"institution","name":"Massachusetts General Hospital Cancer Center","route":"/institutions/mgh/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.massgeneral.org/cancer-center\" }]"}]},{"id":"sirio-libanes","kind":"institution","name":"Hospital Sírio-Libanês","route":"/institutions/sirio-libanes/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.hospitalsiriolibanes.org.br\" }]"}]},{"id":"institut-curie","kind":"institution","name":"Institut Curie","route":"/institutions/institut-curie/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://curie.fr\" }]"}]},{"id":"gemelli","kind":"institution","name":"Policlinico Universitario A. Gemelli","route":"/institutions/gemelli/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.policlinicogemelli.it\" }]"}]},{"id":"lmu-munich","kind":"institution","name":"LMU Klinikum München","route":"/institutions/lmu-munich/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.lmu-klinikum.de\" }]"}]},{"id":"la-paz","kind":"institution","name":"Hospital Universitario La Paz","route":"/institutions/la-paz/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.comunidad.madrid/hospital/lapaz\" }]"}]},{"id":"karolinska","kind":"institution","name":"Karolinska University Hospital","route":"/institutions/karolinska/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.karolinska.se\" }]"}]},{"id":"nci","kind":"institution","name":"National Cancer Institute (NIH)","route":"/institutions/nci/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cancer.gov\" }]"}]},{"id":"moffitt","kind":"institution","name":"Moffitt Cancer Center","route":"/institutions/moffitt/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.moffitt.org\" }]"}]},{"id":"nki","kind":"institution","name":"Netherlands Cancer Institute (NKI-AvL)","route":"/institutions/nki/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.nki.nl\" }]"}]},{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.iarc.who.int\" }]"}]},{"id":"boston-scientific","kind":"company","name":"Boston Scientific","route":"/companies/boston-scientific/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/spikes/hcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bostonscientific.com\" }]"}]},{"id":"aveo","kind":"company","name":"AVEO Oncology (LG Chem)","route":"/companies/aveo/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/spikes/rcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.aveooncology.com\" }]"}]},{"id":"cg-oncology","kind":"company","name":"CG Oncology","route":"/companies/cg-oncology/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://cgoncology.com\" }]"}]},{"id":"bicycle-therapeutics","kind":"company","name":"Bicycle Therapeutics","route":"/companies/bicycle-therapeutics/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bicycletherapeutics.com\" }]"}]},{"id":"cellares","kind":"company","name":"Cellares","route":"/companies/cellares/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cellares.com\" }]"}]},{"id":"catalent","kind":"company","name":"Catalent (Novo Holdings)","route":"/companies/catalent/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.catalent.com\" }]"}]},{"id":"cardinal-health","kind":"company","name":"Cardinal Health Nuclear & Precision Health Solutions","route":"/companies/cardinal-health/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cardinalhealth.com\" }]"}]},{"id":"bruker","kind":"company","name":"Bruker (Bruker Spatial Biology)","route":"/companies/bruker/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bruker.com\" }]"}]},{"id":"brainlab","kind":"company","name":"Brainlab","route":"/companies/brainlab/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.brainlab.com\" }]"}]},{"id":"calyx","kind":"company","name":"Calyx","route":"/companies/calyx/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.calyx.ai\" }]"}]},{"id":"canon-medical","kind":"company","name":"Canon Medical Systems","route":"/companies/canon-medical/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://global.medical.canon\" }]"}]},{"id":"boehringer-ingelheim-biox","kind":"company","name":"Boehringer Ingelheim BioXcellence","route":"/companies/boehringer-ingelheim-biox/","commit":"708b8acc4f","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website links on thirty more institutions and thirty companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.boehringer-ingelheim.com/bioxcellence\" }]"}]},{"id":"arc-institute","kind":"institution","name":"Arc Institute","route":"/institutions/arc-institute/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://arcinstitute.org\" }]"}]},{"id":"asan-medical-center","kind":"institution","name":"Asan Medical Center","route":"/institutions/asan-medical-center/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://eng.amc.seoul.kr\" }]"}]},{"id":"gustave-roussy","kind":"institution","name":"Gustave Roussy","route":"/institutions/gustave-roussy/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.gustaveroussy.fr\" }]"}]},{"id":"charite","kind":"institution","name":"Charité – Universitätsmedizin Berlin","route":"/institutions/charite/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.charite.de\" }]"}]},{"id":"dana-farber","kind":"institution","name":"Dana-Farber Brigham Cancer Center","route":"/institutions/dana-farber/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.dana-farber.org\" }]"}]},{"id":"einstein-sao-paulo","kind":"institution","name":"Hospital Israelita Albert Einstein","route":"/institutions/einstein-sao-paulo/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.einstein.br\" }]"}]},{"id":"heidelberg-nct","kind":"institution","name":"Heidelberg University Hospital / NCT / DKFZ","route":"/institutions/heidelberg-nct/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.nct-heidelberg.de\" }]"}]},{"id":"cleveland-clinic","kind":"institution","name":"Cleveland Clinic Taussig Cancer Institute","route":"/institutions/cleveland-clinic/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://my.clevelandclinic.org/departments/cancer\" }]"}]},{"id":"jfcr","kind":"institution","name":"Cancer Institute Hospital of JFCR","route":"/institutions/jfcr/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.jfcr.or.jp/english/\" }]"}]},{"id":"int-milan","kind":"institution","name":"Fondazione IRCCS Istituto Nazionale dei Tumori","route":"/institutions/int-milan/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.istitutotumori.mi.it\" }]"}]},{"id":"gregorio-maranon","kind":"institution","name":"Hospital General Universitario Gregorio Marañón","route":"/institutions/gregorio-maranon/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.comunidad.madrid/hospital/gregoriomaranon\" }]"}]},{"id":"fred-hutch","kind":"institution","name":"Fred Hutchinson Cancer Center","route":"/institutions/fred-hutch/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.fredhutch.org\" }]"}]},{"id":"penn-abramson","kind":"institution","name":"Abramson Cancer Center, University of Pennsylvania","route":"/institutions/penn-abramson/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.pennmedicine.org/cancer\" }]"}]},{"id":"city-of-hope","kind":"institution","name":"City of Hope","route":"/institutions/city-of-hope/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cityofhope.org\" }]"}]},{"id":"broad-institute","kind":"institution","name":"Broad Institute of MIT and Harvard","route":"/institutions/broad-institute/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.broadinstitute.org\" }]"}]},{"id":"cold-spring-harbor","kind":"institution","name":"Cold Spring Harbor Laboratory","route":"/institutions/cold-spring-harbor/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cshl.edu\" }]"}]},{"id":"cruk","kind":"institution","name":"Cancer Research UK","route":"/institutions/cruk/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cancerresearchuk.org\" }]"}]},{"id":"dkfz","kind":"institution","name":"German Cancer Research Center (DKFZ)","route":"/institutions/dkfz/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.dkfz.de\" }]"}]},{"id":"fuscc","kind":"institution","name":"Fudan University Shanghai Cancer Center","route":"/institutions/fuscc/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.shca.org.cn\" }]"}]},{"id":"cams-cancer-hospital","kind":"institution","name":"Cancer Hospital, Chinese Academy of Medical Sciences","route":"/institutions/cams-cancer-hospital/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.cicams.ac.cn\" }]"}]},{"id":"curie-nki-eortc","kind":"institution","name":"EORTC","route":"/institutions/curie-nki-eortc/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.eortc.org\" }]"}]},{"id":"asco","kind":"institution","name":"American Society of Clinical Oncology (ASCO)","route":"/institutions/asco/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.asco.org\" }]"}]},{"id":"esmo","kind":"institution","name":"European Society for Medical Oncology (ESMO)","route":"/institutions/esmo/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.esmo.org\" }]"}]},{"id":"aacr","kind":"institution","name":"American Association for Cancer Research (AACR)","route":"/institutions/aacr/","commit":"a1202cfd43","date":"2026-09-10","author":"Jude Gomila","message":"Sources: official-website link on thirty institutions that had none","file":"src/data/institutions.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.aacr.org\" }]"}]},{"id":"avenzo","kind":"company","name":"Avenzo Therapeutics","route":"/companies/avenzo/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.avenzotx.com\" }]"}]},{"id":"10x-genomics","kind":"company","name":"10x Genomics","route":"/companies/10x-genomics/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.10xgenomics.com\" }]"}]},{"id":"artera","kind":"company","name":"Artera","route":"/companies/artera/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/companies.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://artera.ai\" }]"}]},{"id":"bioptimus","kind":"company","name":"Bioptimus","route":"/companies/bioptimus/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bioptimus.com\" }]"}]},{"id":"aignostics","kind":"company","name":"Aignostics","route":"/companies/aignostics/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/foundation-models.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.aignostics.com\" }]"}]},{"id":"adaptive-biotechnologies","kind":"company","name":"Adaptive Biotechnologies","route":"/companies/adaptive-biotechnologies/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/spikes/all-leukemia.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.adaptivebiotech.com\" }]"}]},{"id":"bilcap","kind":"trial","name":"BILCAP","route":"/trials/bilcap/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/spikes/cholangiocarcinoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"ISRCTN registry entry (ISRCTN72785446)\", url: \"https://www.isrctn.com/ISRCTN72785446\" }, { label: \"Primrose et al., Lancet Oncology 2019\", url: \"https://doi.org/10.1016/S1470-2045(18)30915-X\" }]"}]},{"id":"blue-earth-diagnostics","kind":"company","name":"Blue Earth Diagnostics (Bracco)","route":"/companies/blue-earth-diagnostics/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.blueearthdiagnostics.com\" }]"}]},{"id":"aldevron","kind":"company","name":"Aldevron (Danaher)","route":"/companies/aldevron/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.aldevron.com\" }]"}]},{"id":"abzena","kind":"company","name":"Abzena","route":"/companies/abzena/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.abzena.com\" }]"}]},{"id":"akoya-biosciences","kind":"company","name":"Akoya Biosciences","route":"/companies/akoya-biosciences/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.akoyabio.com\" }]"}]},{"id":"3dhistech","kind":"company","name":"3DHISTECH","route":"/companies/3dhistech/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.3dhistech.com\" }]"}]},{"id":"agilent","kind":"company","name":"Agilent Technologies (Dako)","route":"/companies/agilent/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.agilent.com\" }]"}]},{"id":"becton-dickinson","kind":"company","name":"BD (Becton, Dickinson and Company)","route":"/companies/becton-dickinson/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bd.com\" }]"}]},{"id":"biolife-solutions","kind":"company","name":"BioLife Solutions","route":"/companies/biolife-solutions/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.biolifesolutions.com\" }]"}]},{"id":"baxter","kind":"company","name":"Baxter International","route":"/companies/baxter/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.baxter.com\" }]"}]},{"id":"b-braun","kind":"company","name":"B. Braun","route":"/companies/b-braun/","commit":"bfc8b4e2d8","date":"2026-09-10","author":"Jude Gomila","message":"Sources: BILCAP registry and publication links; official-website source on nineteen companies","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"Official website\", url: \"https://www.bbraun.com\" }]"}]},{"id":"trastuzumab-deruxtecan","kind":"drug","name":"Trastuzumab deruxtecan","route":"/drugs/trastuzumab-deruxtecan/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20deruxtecan\" }]"}]},{"id":"trastuzumab-emtansine","kind":"drug","name":"Trastuzumab emtansine","route":"/drugs/trastuzumab-emtansine/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20emtansine\" }]"}]},{"id":"tisotumab-vedotin","kind":"drug","name":"Tisotumab vedotin","route":"/drugs/tisotumab-vedotin/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tisotumab%20vedotin\" }]"}]},{"id":"telisotuzumab-vedotin","kind":"drug","name":"Telisotuzumab vedotin","route":"/drugs/telisotuzumab-vedotin/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Telisotuzumab%20vedotin\" }]"}]},{"id":"tarlatamab","kind":"drug","name":"Tarlatamab","route":"/drugs/tarlatamab/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tarlatamab\" }]"}]},{"id":"teclistamab","kind":"drug","name":"Teclistamab","route":"/drugs/teclistamab/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Teclistamab\" }]"}]},{"id":"tebentafusp","kind":"drug","name":"Tebentafusp","route":"/drugs/tebentafusp/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tebentafusp\" }]"}]},{"id":"zanidatamab","kind":"drug","name":"Zanidatamab","route":"/drugs/zanidatamab/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zanidatamab\" }]"}]},{"id":"zenocutuzumab","kind":"drug","name":"Zenocutuzumab","route":"/drugs/zenocutuzumab/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zenocutuzumab\" }]"}]},{"id":"zongertinib","kind":"drug","name":"Zongertinib","route":"/drugs/zongertinib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zongertinib\" }]"}]},{"id":"zidesamtinib","kind":"drug","name":"Zidesamtinib","route":"/drugs/zidesamtinib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zidesamtinib\" }]"}]},{"id":"vepdegestrant","kind":"drug","name":"Vepdegestrant","route":"/drugs/vepdegestrant/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vepdegestrant\" }]"}]},{"id":"vorasidenib","kind":"drug","name":"Vorasidenib","route":"/drugs/vorasidenib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vorasidenib\" }]"}]},{"id":"venetoclax","kind":"drug","name":"Venetoclax","route":"/drugs/venetoclax/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Venetoclax\" }]"}]},{"id":"trastuzumab","kind":"drug","name":"Trastuzumab","route":"/drugs/trastuzumab/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab\" }]"}]},{"id":"tucatinib","kind":"drug","name":"Tucatinib","route":"/drugs/tucatinib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tucatinib\" }]"}]},{"id":"vusolimogene-oderparepvec","kind":"drug","name":"Vusolimogene oderparepvec","route":"/drugs/vusolimogene-oderparepvec/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vusolimogene%20oderparepvec\" }]"}]},{"id":"tisagenlecleucel","kind":"drug","name":"Tisagenlecleucel","route":"/drugs/tisagenlecleucel/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/all-leukemia.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tisagenlecleucel\" }]"}]},{"id":"ziftomenib","kind":"drug","name":"Ziftomenib","route":"/drugs/ziftomenib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ziftomenib\" }]"}]},{"id":"trastuzumab-rezetecan","kind":"drug","name":"Trastuzumab rezetecan","route":"/drugs/trastuzumab-rezetecan/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20rezetecan\" }]"}]},{"id":"trastuzumab-biosimilars","kind":"drug","name":"Trastuzumab biosimilars","route":"/drugs/trastuzumab-biosimilars/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trastuzumab%20biosimilars\" }]"}]},{"id":"tamoxifen","kind":"drug","name":"Tamoxifen","route":"/drugs/tamoxifen/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tamoxifen\" }]"}]},{"id":"zanubrutinib","kind":"drug","name":"Zanubrutinib","route":"/drugs/zanubrutinib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Zanubrutinib\" }]"}]},{"id":"tremelimumab","kind":"drug","name":"Tremelimumab","route":"/drugs/tremelimumab/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tremelimumab\" }]"}]},{"id":"trabectedin","kind":"drug","name":"Trabectedin","route":"/drugs/trabectedin/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/ovarian.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Trabectedin\" }]"}]},{"id":"tivozanib","kind":"drug","name":"Tivozanib","route":"/drugs/tivozanib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/rcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tivozanib\" }]"}]},{"id":"vimseltinib","kind":"drug","name":"Vimseltinib","route":"/drugs/vimseltinib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vimseltinib\" }]"}]},{"id":"topotecan","kind":"drug","name":"Topotecan","route":"/drugs/topotecan/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/sclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Topotecan\" }]"}]},{"id":"vandetanib","kind":"drug","name":"Vandetanib","route":"/drugs/vandetanib/","commit":"3b662d41c0","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for the last approved products without one","file":"src/data/spikes/thyroid.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Vandetanib\" }]"}]},{"id":"sacituzumab-govitecan","kind":"drug","name":"Sacituzumab govitecan","route":"/drugs/sacituzumab-govitecan/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sacituzumab%20govitecan\" }]"}]},{"id":"relatlimab-nivolumab","kind":"drug","name":"Relatlimab + nivolumab","route":"/drugs/relatlimab-nivolumab/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Relatlimab\" }]"}]},{"id":"satricabtagene-autoleucel","kind":"drug","name":"Satricabtagene autoleucel","route":"/drugs/satricabtagene-autoleucel/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Satricabtagene%20autoleucel\" }]"}]},{"id":"sotorasib","kind":"drug","name":"Sotorasib","route":"/drugs/sotorasib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sotorasib\" }]"}]},{"id":"selpercatinib","kind":"drug","name":"Selpercatinib","route":"/drugs/selpercatinib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Selpercatinib\" }]"}]},{"id":"talazoparib","kind":"drug","name":"Talazoparib","route":"/drugs/talazoparib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Talazoparib\" }]"}]},{"id":"ribociclib","kind":"drug","name":"Ribociclib","route":"/drugs/ribociclib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ribociclib\" }]"}]},{"id":"relacorilant","kind":"drug","name":"Relacorilant","route":"/drugs/relacorilant/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Relacorilant\" }]"}]},{"id":"revumenib","kind":"drug","name":"Revumenib","route":"/drugs/revumenib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Revumenib\" }]"}]},{"id":"talimogene-laherparepvec","kind":"drug","name":"Talimogene laherparepvec","route":"/drugs/talimogene-laherparepvec/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Talimogene%20laherparepvec\" }]"}]},{"id":"quizartinib","kind":"drug","name":"Quizartinib","route":"/drugs/quizartinib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Quizartinib\" }]"}]},{"id":"tagraxofusp","kind":"drug","name":"Tagraxofusp","route":"/drugs/tagraxofusp/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tagraxofusp\" }]"}]},{"id":"pyrotinib","kind":"drug","name":"Pyrotinib","route":"/drugs/pyrotinib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pyrotinib\" }]"}]},{"id":"rituximab","kind":"drug","name":"Rituximab","route":"/drugs/rituximab/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rituximab\" }]"}]},{"id":"sonrotoclax","kind":"drug","name":"Sonrotoclax","route":"/drugs/sonrotoclax/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sonrotoclax\" }]"}]},{"id":"tafasitamab","kind":"drug","name":"Tafasitamab","route":"/drugs/tafasitamab/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/dlbcl.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Tafasitamab\" }]"}]},{"id":"selinexor","kind":"drug","name":"Selinexor","route":"/drugs/selinexor/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/endometrial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Selinexor\" }]"}]},{"id":"megestrol-progestins","kind":"drug","name":"Progestins (megestrol acetate, medroxyprogesterone, levonorgestrel IUD)","route":"/drugs/megestrol-progestins/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/endometrial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Progestins\" }]"}]},{"id":"sorafenib","kind":"drug","name":"Sorafenib","route":"/drugs/sorafenib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/hcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sorafenib\" }]"}]},{"id":"talquetamab","kind":"drug","name":"Talquetamab","route":"/drugs/talquetamab/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Talquetamab\" }]"}]},{"id":"octreotide-lanreotide","kind":"drug","name":"Somatostatin analogues (octreotide, lanreotide)","route":"/drugs/octreotide-lanreotide/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/neuroendocrine.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Somatostatin%20analogues\" }]"}]},{"id":"sunitinib","kind":"drug","name":"Sunitinib","route":"/drugs/sunitinib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/neuroendocrine.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Sunitinib\" }]"}]},{"id":"repotrectinib","kind":"drug","name":"Repotrectinib","route":"/drugs/repotrectinib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Repotrectinib\" }]"}]},{"id":"pralsetinib","kind":"drug","name":"Pralsetinib","route":"/drugs/pralsetinib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pralsetinib\" }]"}]},{"id":"rucaparib","kind":"drug","name":"Rucaparib","route":"/drugs/rucaparib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/ovarian.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rucaparib\" }]"}]},{"id":"relugolix","kind":"drug","name":"Relugolix","route":"/drugs/relugolix/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Relugolix\" }]"}]},{"id":"radium-223","kind":"drug","name":"Radium-223 dichloride","route":"/drugs/radium-223/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Radium-223%20dichloride\" }]"}]},{"id":"ripretinib","kind":"drug","name":"Ripretinib","route":"/drugs/ripretinib/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ripretinib\" }]"}]},{"id":"serplulimab","kind":"drug","name":"Serplulimab","route":"/drugs/serplulimab/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/sclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Serplulimab\" }]"}]},{"id":"radioactive-iodine","kind":"drug","name":"Radioactive iodine (I-131)","route":"/drugs/radioactive-iodine/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/thyroid.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Radioactive%20iodine\" }]"}]},{"id":"mirvetuximab-soravtansine","kind":"drug","name":"Mirvetuximab soravtansine","route":"/drugs/mirvetuximab-soravtansine/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Mirvetuximab%20soravtansine\" }]"}]},{"id":"pembrolizumab","kind":"drug","name":"Pembrolizumab","route":"/drugs/pembrolizumab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pembrolizumab\" }]"}]},{"id":"nivolumab","kind":"drug","name":"Nivolumab","route":"/drugs/nivolumab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nivolumab\" }]"}]},{"id":"pylarify","kind":"drug","name":"Piflufolastat F-18 / Pylarify TruVu","route":"/drugs/pylarify/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Piflufolastat%20F-18\" }]"}]},{"id":"osimertinib","kind":"drug","name":"Osimertinib","route":"/drugs/osimertinib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Osimertinib\" }]"}]},{"id":"olaparib","kind":"drug","name":"Olaparib","route":"/drugs/olaparib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Olaparib\" }]"}]},{"id":"niraparib","kind":"drug","name":"Niraparib","route":"/drugs/niraparib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Niraparib\" }]"}]},{"id":"palbociclib","kind":"drug","name":"Palbociclib","route":"/drugs/palbociclib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Palbociclib\" }]"}]},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Paclitaxel\" }]"}]},{"id":"obecabtagene-autoleucel","kind":"drug","name":"Obecabtagene autoleucel","route":"/drugs/obecabtagene-autoleucel/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/all-leukemia.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Obecabtagene%20autoleucel\" }]"}]},{"id":"ponatinib","kind":"drug","name":"Ponatinib","route":"/drugs/ponatinib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/all-leukemia.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ponatinib\" }]"}]},{"id":"midostaurin","kind":"drug","name":"Midostaurin","route":"/drugs/midostaurin/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Midostaurin\" }]"}]},{"id":"olutasidenib","kind":"drug","name":"Olutasidenib","route":"/drugs/olutasidenib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Olutasidenib\" }]"}]},{"id":"pertuzumab","kind":"drug","name":"Pertuzumab","route":"/drugs/pertuzumab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pertuzumab\" }]"}]},{"id":"neratinib","kind":"drug","name":"Neratinib","route":"/drugs/neratinib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Neratinib\" }]"}]},{"id":"margetuximab","kind":"drug","name":"Margetuximab","route":"/drugs/margetuximab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Margetuximab\" }]"}]},{"id":"gardasil-9","kind":"drug","name":"Nonavalent HPV vaccine","route":"/drugs/gardasil-9/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/cervical.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nonavalent%20HPV%20vaccine\" }]"}]},{"id":"pemigatinib","kind":"drug","name":"Pemigatinib","route":"/drugs/pemigatinib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/cholangiocarcinoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pemigatinib\" }]"}]},{"id":"pirtobrutinib","kind":"drug","name":"Pirtobrutinib","route":"/drugs/pirtobrutinib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pirtobrutinib\" }]"}]},{"id":"obinutuzumab","kind":"drug","name":"Obinutuzumab","route":"/drugs/obinutuzumab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Obinutuzumab\" }]"}]},{"id":"polatuzumab-vedotin","kind":"drug","name":"Polatuzumab vedotin","route":"/drugs/polatuzumab-vedotin/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/dlbcl.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Polatuzumab%20vedotin\" }]"}]},{"id":"mosunetuzumab","kind":"drug","name":"Mosunetuzumab","route":"/drugs/mosunetuzumab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/dlbcl.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Mosunetuzumab\" }]"}]},{"id":"odronextamab","kind":"drug","name":"Odronextamab","route":"/drugs/odronextamab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/dlbcl.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Odronextamab\" }]"}]},{"id":"pemetrexed","kind":"drug","name":"Pemetrexed","route":"/drugs/pemetrexed/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/mesothelioma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pemetrexed\" }]"}]},{"id":"naxitamab","kind":"drug","name":"Naxitamab","route":"/drugs/naxitamab/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/neuroblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Naxitamab\" }]"}]},{"id":"pegylated-liposomal-doxorubicin","kind":"drug","name":"Pegylated liposomal doxorubicin","route":"/drugs/pegylated-liposomal-doxorubicin/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/ovarian.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pegylated%20liposomal%20doxorubicin\" }]"}]},{"id":"pazopanib","kind":"drug","name":"Pazopanib","route":"/drugs/pazopanib/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Pazopanib\" }]"}]},{"id":"nirogacestat","kind":"drug","name":"Nirogacestat","route":"/drugs/nirogacestat/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nirogacestat\" }]"}]},{"id":"nogapendekin-alfa","kind":"drug","name":"Nogapendekin alfa inbakicept","route":"/drugs/nogapendekin-alfa/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nogapendekin%20alfa%20inbakicept\" }]"}]},{"id":"nadofaragene-firadenovec","kind":"drug","name":"Nadofaragene firadenovec","route":"/drugs/nadofaragene-firadenovec/","commit":"9cbd69eefa","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fourth batch of thirty approved products","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Nadofaragene%20firadenovec\" }]"}]},{"id":"zynlonta","kind":"drug","name":"Loncastuximab tesirine","route":"/drugs/zynlonta/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Loncastuximab%20tesirine\" }]"}]},{"id":"gemtuzumab-ozogamicin","kind":"drug","name":"Gemtuzumab ozogamicin","route":"/drugs/gemtuzumab-ozogamicin/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gemtuzumab%20ozogamicin\" }]"}]},{"id":"ipilimumab","kind":"drug","name":"Ipilimumab","route":"/drugs/ipilimumab/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ipilimumab\" }]"}]},{"id":"glofitamab","kind":"drug","name":"Glofitamab","route":"/drugs/glofitamab/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Glofitamab\" }]"}]},{"id":"lifileucel","kind":"drug","name":"Lifileucel","route":"/drugs/lifileucel/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lifileucel\" }]"}]},{"id":"pluvicto","kind":"drug","name":"Lutetium-177 vipivotide tetraxetan","route":"/drugs/pluvicto/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lutetium-177%20vipivotide%20tetraxetan\" }]"}]},{"id":"lutathera","kind":"drug","name":"Lutetium-177 dotatate","route":"/drugs/lutathera/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lutetium-177%20dotatate\" }]"}]},{"id":"lorlatinib","kind":"drug","name":"Lorlatinib","route":"/drugs/lorlatinib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lorlatinib\" }]"}]},{"id":"inavolisib","kind":"drug","name":"Inavolisib","route":"/drugs/inavolisib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Inavolisib\" }]"}]},{"id":"gedatolisib","kind":"drug","name":"Gedatolisib","route":"/drugs/gedatolisib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gedatolisib\" }]"}]},{"id":"imatinib","kind":"drug","name":"Imatinib","route":"/drugs/imatinib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Imatinib\" }]"}]},{"id":"inotuzumab-ozogamicin","kind":"drug","name":"Inotuzumab ozogamicin","route":"/drugs/inotuzumab-ozogamicin/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/all-leukemia.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Inotuzumab%20ozogamicin\" }]"}]},{"id":"gilteritinib","kind":"drug","name":"Gilteritinib","route":"/drugs/gilteritinib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gilteritinib\" }]"}]},{"id":"ivosidenib","kind":"drug","name":"Ivosidenib","route":"/drugs/ivosidenib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ivosidenib\" }]"}]},{"id":"lapatinib","kind":"drug","name":"Lapatinib","route":"/drugs/lapatinib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/breast-her2-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lapatinib\" }]"}]},{"id":"fulvestrant","kind":"drug","name":"Fulvestrant","route":"/drugs/fulvestrant/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fulvestrant\" }]"}]},{"id":"imlunestrant","kind":"drug","name":"Imlunestrant","route":"/drugs/imlunestrant/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Imlunestrant\" }]"}]},{"id":"goserelin","kind":"drug","name":"Goserelin / leuprolide (ovarian function suppression)","route":"/drugs/goserelin/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Goserelin\" }]"}]},{"id":"ibrutinib","kind":"drug","name":"Ibrutinib","route":"/drugs/ibrutinib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ibrutinib\" }]"}]},{"id":"lisocabtagene-maraleucel","kind":"drug","name":"Lisocabtagene maraleucel","route":"/drugs/lisocabtagene-maraleucel/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lisocabtagene%20maraleucel\" }]"}]},{"id":"lenalidomide","kind":"drug","name":"Lenalidomide","route":"/drugs/lenalidomide/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lenalidomide\" }]"}]},{"id":"isatuximab","kind":"drug","name":"Isatuximab","route":"/drugs/isatuximab/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Isatuximab\" }]"}]},{"id":"idecabtagene-vicleucel","kind":"drug","name":"Idecabtagene vicleucel","route":"/drugs/idecabtagene-vicleucel/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Idecabtagene%20vicleucel\" }]"}]},{"id":"linvoseltamab","kind":"drug","name":"Linvoseltamab","route":"/drugs/linvoseltamab/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Linvoseltamab\" }]"}]},{"id":"lazertinib","kind":"drug","name":"Lazertinib","route":"/drugs/lazertinib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lazertinib\" }]"}]},{"id":"letrozole","kind":"drug","name":"Letrozole (and other aromatase inhibitors)","route":"/drugs/letrozole/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/ovarian.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Letrozole\" }]"}]},{"id":"ga68-psma-11","kind":"drug","name":"Gallium-68 gozetotide (PSMA-11)","route":"/drugs/ga68-psma-11/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Gallium-68%20gozetotide\" }]"}]},{"id":"lenvatinib","kind":"drug","name":"Lenvatinib","route":"/drugs/lenvatinib/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/rcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lenvatinib\" }]"}]},{"id":"ifosfamide","kind":"drug","name":"Ifosfamide","route":"/drugs/ifosfamide/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ifosfamide\" }]"}]},{"id":"lurbinectedin","kind":"drug","name":"Lurbinectedin","route":"/drugs/lurbinectedin/","commit":"925a04b429","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a third batch of thirty approved products","file":"src/data/spikes/sclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Lurbinectedin\" }]"}]},{"id":"datopotamab-deruxtecan","kind":"drug","name":"Datopotamab deruxtecan","route":"/drugs/datopotamab-deruxtecan/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Datopotamab%20deruxtecan\" }]"}]},{"id":"enfortumab-vedotin","kind":"drug","name":"Enfortumab vedotin","route":"/drugs/enfortumab-vedotin/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Enfortumab%20vedotin\" }]"}]},{"id":"disitamab-vedotin","kind":"drug","name":"Disitamab vedotin","route":"/drugs/disitamab-vedotin/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Disitamab%20vedotin\" }]"}]},{"id":"durvalumab","kind":"drug","name":"Durvalumab","route":"/drugs/durvalumab/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Durvalumab\" }]"}]},{"id":"dostarlimab","kind":"drug","name":"Dostarlimab","route":"/drugs/dostarlimab/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dostarlimab\" }]"}]},{"id":"cemiplimab","kind":"drug","name":"Cemiplimab","route":"/drugs/cemiplimab/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cemiplimab\" }]"}]},{"id":"ciltacabtagene-autoleucel","kind":"drug","name":"Ciltacabtagene autoleucel","route":"/drugs/ciltacabtagene-autoleucel/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ciltacabtagene%20autoleucel\" }]"}]},{"id":"encorafenib","kind":"drug","name":"Encorafenib","route":"/drugs/encorafenib/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Encorafenib\" }]"}]},{"id":"elacestrant","kind":"drug","name":"Elacestrant","route":"/drugs/elacestrant/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Elacestrant\" }]"}]},{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Carboplatin\" }]"}]},{"id":"dasatinib","kind":"drug","name":"Dasatinib","route":"/drugs/dasatinib/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/all-leukemia.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dasatinib\" }]"}]},{"id":"decitabine-cedazuridine","kind":"drug","name":"Decitabine + cedazuridine (oral)","route":"/drugs/decitabine-cedazuridine/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Decitabine\" }]"}]},{"id":"enasidenib","kind":"drug","name":"Enasidenib","route":"/drugs/enasidenib/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Enasidenib\" }]"}]},{"id":"exemestane","kind":"drug","name":"Exemestane","route":"/drugs/exemestane/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Exemestane\" }]"}]},{"id":"cisplatin","kind":"drug","name":"Cisplatin","route":"/drugs/cisplatin/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/cervical.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cisplatin\" }]"}]},{"id":"epcoritamab","kind":"drug","name":"Epcoritamab","route":"/drugs/epcoritamab/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/dlbcl.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Epcoritamab\" }]"}]},{"id":"cobimetinib","kind":"drug","name":"Cobimetinib","route":"/drugs/cobimetinib/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/melanoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cobimetinib\" }]"}]},{"id":"carfilzomib","kind":"drug","name":"Carfilzomib","route":"/drugs/carfilzomib/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Carfilzomib\" }]"}]},{"id":"daratumumab","kind":"drug","name":"Daratumumab","route":"/drugs/daratumumab/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Daratumumab\" }]"}]},{"id":"elranatamab","kind":"drug","name":"Elranatamab","route":"/drugs/elranatamab/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Elranatamab\" }]"}]},{"id":"dinutuximab","kind":"drug","name":"Dinutuximab (ch14.18) / dinutuximab beta","route":"/drugs/dinutuximab/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/neuroblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dinutuximab/%20dinutuximab%20beta\" }]"}]},{"id":"eflornithine","kind":"drug","name":"Eflornithine (DFMO)","route":"/drugs/eflornithine/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/neuroblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Eflornithine\" }]"}]},{"id":"everolimus","kind":"drug","name":"Everolimus","route":"/drugs/everolimus/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/neuroendocrine.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Everolimus\" }]"}]},{"id":"dabrafenib-trametinib","kind":"drug","name":"Dabrafenib + trametinib","route":"/drugs/dabrafenib-trametinib/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Dabrafenib\" }]"}]},{"id":"enzalutamide","kind":"drug","name":"Enzalutamide","route":"/drugs/enzalutamide/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Enzalutamide\" }]"}]},{"id":"darolutamide","kind":"drug","name":"Darolutamide","route":"/drugs/darolutamide/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Darolutamide\" }]"}]},{"id":"docetaxel","kind":"drug","name":"Docetaxel","route":"/drugs/docetaxel/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Docetaxel\" }]"}]},{"id":"flotufolastat","kind":"drug","name":"Flotufolastat F-18","route":"/drugs/flotufolastat/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Flotufolastat%20F-18\" }]"}]},{"id":"doxorubicin","kind":"drug","name":"Doxorubicin","route":"/drugs/doxorubicin/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Doxorubicin\" }]"}]},{"id":"erdafitinib","kind":"drug","name":"Erdafitinib","route":"/drugs/erdafitinib/","commit":"08f191a505","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty more approved products","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Erdafitinib\" }]"}]},{"id":"brentuximab-vedotin","kind":"drug","name":"Brentuximab vedotin","route":"/drugs/brentuximab-vedotin/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Brentuximab%20vedotin\" }]"}]},{"id":"belantamab-mafodotin","kind":"drug","name":"Belantamab mafodotin","route":"/drugs/belantamab-mafodotin/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Belantamab%20mafodotin\" }]"}]},{"id":"atezolizumab","kind":"drug","name":"Atezolizumab","route":"/drugs/atezolizumab/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Atezolizumab\" }]"}]},{"id":"blinatumomab","kind":"drug","name":"Blinatumomab","route":"/drugs/blinatumomab/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Blinatumomab\" }]"}]},{"id":"amivantamab","kind":"drug","name":"Amivantamab","route":"/drugs/amivantamab/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Amivantamab\" }]"}]},{"id":"axicabtagene-ciloleucel","kind":"drug","name":"Axicabtagene ciloleucel","route":"/drugs/axicabtagene-ciloleucel/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Axicabtagene%20ciloleucel\" }]"}]},{"id":"afamitresgene-autoleucel","kind":"drug","name":"Afamitresgene autoleucel","route":"/drugs/afamitresgene-autoleucel/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Afamitresgene%20autoleucel\" }]"}]},{"id":"adagrasib","kind":"drug","name":"Adagrasib","route":"/drugs/adagrasib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Adagrasib\" }]"}]},{"id":"abemaciclib","kind":"drug","name":"Abemaciclib","route":"/drugs/abemaciclib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Abemaciclib\" }]"}]},{"id":"capivasertib","kind":"drug","name":"Capivasertib","route":"/drugs/capivasertib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Capivasertib\" }]"}]},{"id":"belzutifan","kind":"drug","name":"Belzutifan","route":"/drugs/belzutifan/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/drugs.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Belzutifan\" }]"}]},{"id":"asciminib","kind":"drug","name":"Asciminib","route":"/drugs/asciminib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/all-leukemia.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Asciminib\" }]"}]},{"id":"azacitidine","kind":"drug","name":"Azacitidine","route":"/drugs/azacitidine/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/aml.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Azacitidine\" }]"}]},{"id":"camizestrant","kind":"drug","name":"Camizestrant","route":"/drugs/camizestrant/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Camizestrant\" }]"}]},{"id":"alpelisib","kind":"drug","name":"Alpelisib","route":"/drugs/alpelisib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Alpelisib\" }]"}]},{"id":"cadonilimab","kind":"drug","name":"Cadonilimab","route":"/drugs/cadonilimab/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/cervical.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cadonilimab\" }]"}]},{"id":"acalabrutinib","kind":"drug","name":"Acalabrutinib","route":"/drugs/acalabrutinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/cll.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Acalabrutinib\" }]"}]},{"id":"bevacizumab-glioma","kind":"drug","name":"Bevacizumab (glioblastoma use)","route":"/drugs/bevacizumab-glioma/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/glioblastoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Bevacizumab\" }]"}]},{"id":"binimetinib","kind":"drug","name":"Binimetinib","route":"/drugs/binimetinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/melanoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Binimetinib\" }]"}]},{"id":"bortezomib","kind":"drug","name":"Bortezomib","route":"/drugs/bortezomib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/multiple-myeloma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Bortezomib\" }]"}]},{"id":"alectinib","kind":"drug","name":"Alectinib","route":"/drugs/alectinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Alectinib\" }]"}]},{"id":"capmatinib-tepotinib","kind":"drug","name":"Capmatinib & tepotinib","route":"/drugs/capmatinib-tepotinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Capmatinib%20%26%20tepotinib\" }]"}]},{"id":"avutometinib-defactinib","kind":"drug","name":"Avutometinib + defactinib","route":"/drugs/avutometinib-defactinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/ovarian.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Avutometinib\" }]"}]},{"id":"abiraterone","kind":"drug","name":"Abiraterone acetate","route":"/drugs/abiraterone/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Abiraterone%20acetate\" }]"}]},{"id":"apalutamide","kind":"drug","name":"Apalutamide","route":"/drugs/apalutamide/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Apalutamide\" }]"}]},{"id":"cabazitaxel","kind":"drug","name":"Cabazitaxel","route":"/drugs/cabazitaxel/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cabazitaxel\" }]"}]},{"id":"axitinib","kind":"drug","name":"Axitinib","route":"/drugs/axitinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/rcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Axitinib\" }]"}]},{"id":"cabozantinib","kind":"drug","name":"Cabozantinib","route":"/drugs/cabozantinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/rcc.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cabozantinib\" }]"}]},{"id":"avapritinib","kind":"drug","name":"Avapritinib","route":"/drugs/avapritinib/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/sarcoma.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Avapritinib\" }]"}]},{"id":"avelumab","kind":"drug","name":"Avelumab","route":"/drugs/avelumab/","commit":"e03f56897d","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for thirty approved products that had none","file":"src/data/spikes/urothelial.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Avelumab\" }]"}]},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/","commit":"91a4bba51c","date":"2026-09-10","author":"Jude Gomila","message":"Fourteen orphan products now linked from their targets and cancers (ALK, EGFR, ROS1, ER, FOLR1 inhibitors and tracers; myeloma, prostate, gl","file":"src/data/cancers.ts","type":"changed","fields":[{"field":"drugs","after":"[\"elotuzumab\", \"panobinostat\", \"sipuleucel-t\", \"fluciclovine-f18\", \"aminolevulinic-acid-gleolan\", \"pegulicianine\"]"}]},{"id":"ros1","kind":"target","name":"ROS1","route":"/targets/ros1/","commit":"91a4bba51c","date":"2026-09-10","author":"Jude Gomila","message":"Fourteen orphan products now linked from their targets and cancers (ALK, EGFR, ROS1, ER, FOLR1 inhibitors and tracers; myeloma, prostate, gl","file":"src/data/spikes/nsclc.ts","type":"changed","fields":[{"field":"drugs","before":"[\"repotrectinib\", \"zidesamtinib\"]","after":"[\"repotrectinib\", \"zidesamtinib\", \"taletrectinib\"]"}]},{"id":"egfr","kind":"target","name":"EGFR","route":"/targets/egfr/","commit":"91a4bba51c","date":"2026-09-10","author":"Jude Gomila","message":"Fourteen orphan products now linked from their targets and cancers (ALK, EGFR, ROS1, ER, FOLR1 inhibitors and tracers; myeloma, prostate, gl","file":"src/data/targets.ts","type":"changed","fields":[{"field":"drugs","after":"[\"dacomitinib\", \"mobocertinib\"]"}]},{"id":"folr1","kind":"target","name":"Folate receptor alpha","route":"/targets/folr1/","commit":"91a4bba51c","date":"2026-09-10","author":"Jude Gomila","message":"Fourteen orphan products now linked from their targets and cancers (ALK, EGFR, ROS1, ER, FOLR1 inhibitors and tracers; myeloma, prostate, gl","file":"src/data/targets.ts","type":"changed","fields":[{"field":"drugs","after":"[\"pafolacianine\"]"}]},{"id":"alk","kind":"target","name":"ALK","route":"/targets/alk/","commit":"91a4bba51c","date":"2026-09-10","author":"Jude Gomila","message":"Fourteen orphan products now linked from their targets and cancers (ALK, EGFR, ROS1, ER, FOLR1 inhibitors and tracers; myeloma, prostate, gl","file":"src/data/targets.ts","type":"changed","fields":[{"field":"drugs","after":"[\"ceritinib\", \"brigatinib\", \"ensartinib\"]"}]},{"id":"estrogen-receptor","kind":"target","name":"Estrogen receptor (ERα)","route":"/targets/estrogen-receptor/","commit":"91a4bba51c","date":"2026-09-10","author":"Jude Gomila","message":"Fourteen orphan products now linked from their targets and cancers (ALK, EGFR, ROS1, ER, FOLR1 inhibitors and tracers; myeloma, prostate, gl","file":"src/data/targets.ts","type":"changed","fields":[{"field":"drugs","after":"[\"fluoroestradiol-f18\"]"}]},{"id":"hydrazone","kind":"term","name":"Acid-labile hydrazone (AcBut)","route":"/terms/hydrazone/","commit":"504f15547c","date":"2026-09-10","author":"Jude Gomila","message":"Fix: Wikipedia link belongs on the hydrazone glossary term, not the linker registry row","file":"src/data/payloads.ts","type":"changed","fields":[{"field":"wikipedia","before":"\"https://en.wikipedia.org/wiki/Hydrazone\""}]},{"id":"cancer-health-disparities","kind":"term","name":"Cancer health disparities and equity","route":"/terms/cancer-health-disparities/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/gap-fill.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Health_equity\""}]},{"id":"aya-oncology","kind":"term","name":"Adolescent and young adult (AYA) oncology","route":"/terms/aya-oncology/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/gap-fill.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Adolescent_and_young_adult_oncology\""}]},{"id":"financial-toxicity","kind":"term","name":"Financial toxicity","route":"/terms/financial-toxicity/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/gap-fill.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Financial_toxicity\""}]},{"id":"evading-growth-suppressors","kind":"term","name":"Hallmark: evading growth suppressors","route":"/terms/evading-growth-suppressors/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"resisting-cell-death","kind":"term","name":"Hallmark: resisting cell death","route":"/terms/resisting-cell-death/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"enabling-replicative-immortality","kind":"term","name":"Hallmark: enabling replicative immortality","route":"/terms/enabling-replicative-immortality/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"inducing-angiogenesis","kind":"term","name":"Hallmark: inducing or accessing vasculature","route":"/terms/inducing-angiogenesis/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"activating-invasion-metastasis","kind":"term","name":"Hallmark: activating invasion and metastasis","route":"/terms/activating-invasion-metastasis/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"deregulating-cellular-energetics","kind":"term","name":"Hallmark: reprogramming cellular metabolism","route":"/terms/deregulating-cellular-energetics/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"avoiding-immune-destruction","kind":"term","name":"Hallmark: avoiding immune destruction","route":"/terms/avoiding-immune-destruction/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"genome-instability-mutation","kind":"term","name":"Enabling characteristic: genome instability and mutation","route":"/terms/genome-instability-mutation/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"tumor-promoting-inflammation","kind":"term","name":"Enabling characteristic: tumour-promoting inflammation","route":"/terms/tumor-promoting-inflammation/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"unlocking-phenotypic-plasticity","kind":"term","name":"Hallmark (2022): unlocking phenotypic plasticity","route":"/terms/unlocking-phenotypic-plasticity/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"nonmutational-epigenetic-reprogramming","kind":"term","name":"Hallmark (2022): non-mutational epigenetic reprogramming","route":"/terms/nonmutational-epigenetic-reprogramming/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"polymorphic-microbiomes","kind":"term","name":"Hallmark (2022): polymorphic microbiomes","route":"/terms/polymorphic-microbiomes/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/The_Hallmarks_of_Cancer\""}]},{"id":"senescent-cells","kind":"term","name":"Hallmark (2022): senescent cells","route":"/terms/senescent-cells/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/mechanisms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Cellular_senescence\""}]},{"id":"hydrazone","kind":"term","name":"Acid-labile hydrazone (AcBut)","route":"/terms/hydrazone/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/payloads.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Hydrazone\""}]},{"id":"endocrine-resistance","kind":"term","name":"Endocrine resistance","route":"/terms/endocrine-resistance/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/spikes/breast-hr-positive.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Hormone_therapy_(oncology)\""}]},{"id":"double-hit-lymphoma","kind":"term","name":"Double-hit / high-grade B-cell lymphoma","route":"/terms/double-hit-lymphoma/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/spikes/dlbcl.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Double-hit_lymphoma\""}]},{"id":"deauville-score","kind":"term","name":"Deauville five-point scale","route":"/terms/deauville-score/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/spikes/hodgkin-lymphoma.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Deauville_criteria\""}]},{"id":"epithelioid-vs-sarcomatoid","kind":"term","name":"Epithelioid vs sarcomatoid (biphasic) mesothelioma","route":"/terms/epithelioid-vs-sarcomatoid/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/spikes/mesothelioma.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Mesothelioma\""}]},{"id":"340b-program","kind":"term","name":"340B Drug Pricing Program","route":"/terms/340b-program/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/340B_Drug_Pricing_Program\""}]},{"id":"bicr","kind":"term","name":"Blinded independent central review (BICR)","route":"/terms/bicr/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Blinded_experiment\""}]},{"id":"cdmo","kind":"term","name":"CDMO (contract development and manufacturing organisation)","route":"/terms/cdmo/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Contract_development_and_manufacturing_organization\""}]},{"id":"biosecure-act","kind":"term","name":"BIOSECURE Act","route":"/terms/biosecure-act/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/supporting.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/BIOSECURE_Act\""}]},{"id":"efs","kind":"term","name":"Event-free / disease-free survival (EFS, DFS, iDFS, RFS)","route":"/terms/efs/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/terms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Disease-free_survival\""}]},{"id":"breakthrough-designation","kind":"term","name":"Breakthrough Therapy / Priority Review / Priority Voucher","route":"/terms/breakthrough-designation/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/terms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Breakthrough_therapy\""}]},{"id":"companion-diagnostic-term","kind":"term","name":"Companion diagnostic","route":"/terms/companion-diagnostic-term/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/terms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Companion_diagnostic\""}]},{"id":"dosimetry","kind":"term","name":"Dosimetry","route":"/terms/dosimetry/","commit":"3c0138f0f0","date":"2026-09-10","author":"Jude Gomila","message":"Glossary: Wikipedia links for thirty terms (hallmarks, regulatory, ADC chemistry, endpoints); calendar entry without an em-dash","file":"src/data/terms.ts","type":"changed","fields":[{"field":"wikipedia","after":"\"https://en.wikipedia.org/wiki/Dosimetry\""}]},{"id":"osimertinib","kind":"drug","name":"Osimertinib","route":"/drugs/osimertinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"hepatic"},{"field":"source"}]},{"id":"erlotinib","kind":"drug","name":"Erlotinib","route":"/drugs/erlotinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"gefitinib","kind":"drug","name":"Gefitinib","route":"/drugs/gefitinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"hepatic"},{"field":"source"}]},{"id":"afatinib","kind":"drug","name":"Afatinib","route":"/drugs/afatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"renal"},{"field":"source"}]},{"id":"lazertinib","kind":"drug","name":"Lazertinib","route":"/drugs/lazertinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"source"}]},{"id":"alectinib","kind":"drug","name":"Alectinib","route":"/drugs/alectinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"lorlatinib","kind":"drug","name":"Lorlatinib","route":"/drugs/lorlatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"source"}]},{"id":"brigatinib","kind":"drug","name":"Brigatinib","route":"/drugs/brigatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"crizotinib","kind":"drug","name":"Crizotinib","route":"/drugs/crizotinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"hepatic"},{"field":"source"}]},{"id":"entrectinib","kind":"drug","name":"Entrectinib","route":"/drugs/entrectinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"repotrectinib","kind":"drug","name":"Repotrectinib","route":"/drugs/repotrectinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"larotrectinib","kind":"drug","name":"Larotrectinib","route":"/drugs/larotrectinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"selpercatinib","kind":"drug","name":"Selpercatinib","route":"/drugs/selpercatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"hepatic"},{"field":"source"}]},{"id":"pralsetinib","kind":"drug","name":"Pralsetinib","route":"/drugs/pralsetinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"capmatinib-tepotinib","kind":"drug","name":"Capmatinib & tepotinib","route":"/drugs/capmatinib-tepotinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"amivantamab","kind":"drug","name":"Amivantamab","route":"/drugs/amivantamab/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"food"},{"field":"source"}]},{"id":"sunvozertinib","kind":"drug","name":"Sunvozertinib","route":"/drugs/sunvozertinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"sotorasib","kind":"drug","name":"Sotorasib","route":"/drugs/sotorasib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"hepatic"},{"field":"source"}]},{"id":"adagrasib","kind":"drug","name":"Adagrasib","route":"/drugs/adagrasib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"source"}]},{"id":"encorafenib","kind":"drug","name":"Encorafenib","route":"/drugs/encorafenib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"source"}]},{"id":"dabrafenib-trametinib","kind":"drug","name":"Dabrafenib + trametinib","route":"/drugs/dabrafenib-trametinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"vemurafenib","kind":"drug","name":"Vemurafenib","route":"/drugs/vemurafenib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"tovorafenib","kind":"drug","name":"Tovorafenib","route":"/drugs/tovorafenib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"pairs"},{"field":"source"}]},{"id":"lapatinib","kind":"drug","name":"Lapatinib","route":"/drugs/lapatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"tucatinib","kind":"drug","name":"Tucatinib","route":"/drugs/tucatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"hepatic"},{"field":"source"}]},{"id":"neratinib","kind":"drug","name":"Neratinib","route":"/drugs/neratinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"palbociclib","kind":"drug","name":"Palbociclib","route":"/drugs/palbociclib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"ribociclib","kind":"drug","name":"Ribociclib","route":"/drugs/ribociclib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"abemaciclib","kind":"drug","name":"Abemaciclib","route":"/drugs/abemaciclib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"alpelisib","kind":"drug","name":"Alpelisib","route":"/drugs/alpelisib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"inavolisib","kind":"drug","name":"Inavolisib","route":"/drugs/inavolisib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"pairs"},{"field":"source"}]},{"id":"capivasertib","kind":"drug","name":"Capivasertib","route":"/drugs/capivasertib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"elacestrant","kind":"drug","name":"Elacestrant","route":"/drugs/elacestrant/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"tamoxifen","kind":"drug","name":"Tamoxifen","route":"/drugs/tamoxifen/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"source"}]},{"id":"letrozole","kind":"drug","name":"Letrozole (and other aromatase inhibitors)","route":"/drugs/letrozole/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"source"}]},{"id":"exemestane","kind":"drug","name":"Exemestane","route":"/drugs/exemestane/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"abiraterone","kind":"drug","name":"Abiraterone acetate","route":"/drugs/abiraterone/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"enzalutamide","kind":"drug","name":"Enzalutamide","route":"/drugs/enzalutamide/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"apalutamide","kind":"drug","name":"Apalutamide","route":"/drugs/apalutamide/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"pairs"},{"field":"source"}]},{"id":"darolutamide","kind":"drug","name":"Darolutamide","route":"/drugs/darolutamide/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"ibrutinib","kind":"drug","name":"Ibrutinib","route":"/drugs/ibrutinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"acalabrutinib","kind":"drug","name":"Acalabrutinib","route":"/drugs/acalabrutinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"hepatic"},{"field":"source"}]},{"id":"zanubrutinib","kind":"drug","name":"Zanubrutinib","route":"/drugs/zanubrutinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"hepatic"},{"field":"source"}]},{"id":"pirtobrutinib","kind":"drug","name":"Pirtobrutinib","route":"/drugs/pirtobrutinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"venetoclax","kind":"drug","name":"Venetoclax","route":"/drugs/venetoclax/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"idelalisib","kind":"drug","name":"Idelalisib","route":"/drugs/idelalisib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"hepatic"},{"field":"source"}]},{"id":"lenalidomide","kind":"drug","name":"Lenalidomide","route":"/drugs/lenalidomide/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"pairs"},{"field":"renal"},{"field":"source"}]},{"id":"pomalidomide","kind":"drug","name":"Pomalidomide","route":"/drugs/pomalidomide/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"bortezomib","kind":"drug","name":"Bortezomib","route":"/drugs/bortezomib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"hepatic"},{"field":"source"}]},{"id":"ixazomib","kind":"drug","name":"Ixazomib","route":"/drugs/ixazomib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"imatinib","kind":"drug","name":"Imatinib","route":"/drugs/imatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"food"},{"field":"source"}]},{"id":"dasatinib","kind":"drug","name":"Dasatinib","route":"/drugs/dasatinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"nilotinib","kind":"drug","name":"Nilotinib","route":"/drugs/nilotinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"bosutinib","kind":"drug","name":"Bosutinib","route":"/drugs/bosutinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]},{"id":"asciminib","kind":"drug","name":"Asciminib","route":"/drugs/asciminib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"ruxolitinib","kind":"drug","name":"Ruxolitinib","route":"/drugs/ruxolitinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"renal"},{"field":"source"}]},{"id":"midostaurin","kind":"drug","name":"Midostaurin","route":"/drugs/midostaurin/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"source"}]},{"id":"gilteritinib","kind":"drug","name":"Gilteritinib","route":"/drugs/gilteritinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"source"}]},{"id":"quizartinib","kind":"drug","name":"Quizartinib","route":"/drugs/quizartinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"ivosidenib","kind":"drug","name":"Ivosidenib","route":"/drugs/ivosidenib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"pairs"},{"field":"source"}]},{"id":"revumenib","kind":"drug","name":"Revumenib","route":"/drugs/revumenib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"source"}]},{"id":"selinexor","kind":"drug","name":"Selinexor","route":"/drugs/selinexor/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"food"},{"field":"source"}]},{"id":"olaparib","kind":"drug","name":"Olaparib","route":"/drugs/olaparib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"renal"},{"field":"source"}]},{"id":"niraparib","kind":"drug","name":"Niraparib","route":"/drugs/niraparib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"food"},{"field":"source"}]},{"id":"rucaparib","kind":"drug","name":"Rucaparib","route":"/drugs/rucaparib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"pairs"},{"field":"source"}]},{"id":"talazoparib","kind":"drug","name":"Talazoparib","route":"/drugs/talazoparib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"renal"},{"field":"source"}]},{"id":"cabozantinib","kind":"drug","name":"Cabozantinib","route":"/drugs/cabozantinib/","commit":"57b67248b1","date":"2026-09-10","author":"Jude Gomila","message":"Improvements batch B: clinician power tools","file":"src/data/interactions.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"class"},{"field":"props"},{"field":"management"},{"field":"food"},{"field":"hepatic"},{"field":"source"}]}]}